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TRYPANOSOMA BRUCEI TELOMERE FUNCTIONS IN ANTIGENIC
VARIATION
UNNATI M. PANDYA
ABSTRACT
Trypanosoma brucei is a protozoan parasite that causes sleeping sickness in
humans and Nagana in cattle. They evade the host’s immune defense by
periodically switching their major surface antigen, variant surface glycoprotein
(VSG), a phenomenon termed antigenic variation. Inside its mammalian host,
bloodstream form (BF) T. brucei monoallelically expresses its major surface
molecule VSG from the VSG Expression Sites (ESs) located at subtelomeric loci.
Monoallelic VSG expression ensures effective antigenic variation and maximizes
the efficiency of T. brucei pathogenesis. In the mid-gut of its insect host (tsetse),
procyclic form (PF) T. brucei expresses procyclins as the major surface
molecules and all VSGs are silent. After the migration to the salivary glands of
the tsetse fly, T. brucei cells differentiate into metacyclic forms and express
metacyclic VSGs (mVSGs). Therefore, VSG silencing is important for the normal
development of T. brucei.
Telomeres are important for the regulation of antigenic variation. TbRAP1 was
previously identified as an intrinsic component of the T. brucei telomere complex
and was shown to be important for ES-linked VSG silencing in BF cells. Our
studies further established that TbRAP1 is essential for cell proliferation and
required for VSG silencing in PF cells. Apart form ES-linked VSGs, TbRAP1 also
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regulates the silencing of mVSGs in both BF and PF cells. The strength of
TbRAP1 mediated VSG silencing is stronger in PF cells compared to that in the
BF cells. In addition, the TbRAP1-mediated VSG silencing in PF cells involves
chromatin remodeling.
TbTRF, a duplex telomere DNA binding protein that interacts with TbRAP1,
does not affect VSG silencing but regulates telomere structure. TbTRFH (TRF
homology domain) is required for the homodimerization of TbTRF as well as for
interaction with TbRAP1. We established several TbTRFH mutants and
determined the critical regions required for homodimerization of TbTRF by
performing yeast two-hybrid analysis.
TERRA (telomeric repeat- containing RNA) is known to play an important role
in the regulation of the higher order chromatin structure at telomeres in
mammalian cells. We characterized TERRA in T. brucei in order to determine its
role in VSG silencing. We determined that a significant amount of TERRA is
transcribed from the active ES-linked telomere. Also, TbTRF and TbKU80
interact with TERRA in vivo. Telomere proteins were found to play an important
role in regulating TERRA levels. Most importantly, lower levels of TERRA led to
mild de-repression of silent VSGs in BF form T. brucei cells, indicating that
TERRA indeed is involved in VSG silencing.
Our study provides insight into various mechanisms of how telomeres
contribute to antigenic variation regulation in T. brucei, which helps to better
understand pathogenesis of T. brucei and to achieve its eradication.
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CHAPTER I
INTRODUCTION

African trypanosomiasis: Cause, Clinical features, and Epidemiology
Trypanosomes are a large group of protozoan parasites belonging to the
class kinetoplastida and the genus Trypanosoma causing diseases in man and
animals. Trypanosoma brucei is the causative agent of Human African
Trypanosomiasis (HAT), more commonly known as ‘sleeping sickness’. They
also cause Animal African Trypanosomiasis (AAT) or ‘nagana’ in cattle.
Trypanosoma brucei is transmitted by a blood-sucking tsetse fly belonging to
genus Glossina. HAT occurs throughout tropical and sub-tropical sub-Saharan
Africa, and 60 million people are estimated to be at risk (Atouguia and Kennedy,
2000, Kennedy 2004 and Brun et al. 2010). Approximately 50 million cattle are at
risk of trypanosome infection and the major cause of mortality is due to severe
outbreaks leading to depressed productivity and economical set back (Shaw,
2004). HAT is widespread in an area of about 10 million km2 in Africa (Kennedy,
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2004), and it can be fatal if left untreated. The major pathogenic HAT-causing
species are Trypanosoma brucei rhodesiense and Trypanosoma brucei
gambiense. They cause East African disease and West African disease,
respectively (Brun et al. 2010, Kennedy 2004). 97% of chronic cases of HAT are
caused by Trypanosoma brucei gambiense and the remaining 3% that are more
acute and severe are caused by Trypanosoma brucei rhodesiense (Simmaro et
al. 2008). T. b. congolense, T. b. vivax, and T. b. brucei infect cattle, sheep,
goat, horse, and donkey. T. b. simiae infects pigs (Holmes, 2013).
T. b. brucei that causes African Trypanosomiasis in animals is highly
susceptible to lytic factors present in the human serum known as trypanosome
lytic factors (TLFs). Due to this reason, animal infecting trypanosomes are noninfective in humans (Capewell et al. 2011). However, T. b. brucei is highly similar
to T. b. gambiense. This property makes it suitable for laboratory research. There
are two types of TLFs present in humans: (1) TLF-1 – a high-density lipoprotein
particle (Rifkin, 1978) and (2) TLF-2 – a serum protein-binding complex (Raper et
al. 1999 and Capewell et al. 2011). T. b. rhodesiense expresses serum
resistance protein (SRA) encoded by the SRA gene. SRA binds TLF-1, making
parasite resistant to lysis in humans (Capewell et al. 2011 and Kieft et al. 2012).
T. b. gambiense, on the other hand, utilizes a different mechanism to prevent
lysis. It reduces the expression of haptoglobin-haemoglobin receptor required for
binding and uptake of TLF-1 by the parasite (Capewell et al. 2011 and Kieft et al.
2012).
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Thousands of people died during the time span when this disease was first
discovered (1896-1906) (Brun et al. 2010 and Kennedy, 2010). However, the
cases declined in the following years due to strong measures, such as mass
sacrifice of animals, eradication of large forested regions, and increased human
surveillance for disease and treatment (Peter, 2013). Only a few cases were
reported in the 1960s (Brun et al. 2010, Kennedy, 2010 and Simarro et al. 2011).
Later, the number of cases grew to 300,000 in 1998 due to the decline in human
case surveillance and several other factors such as war, famine and
socioeconomic instability (World Health Organization, 1998). These numbers
declined eventually due to better vector control and treatment. In 2009, the
number of cases reported by the World Health Organization (WHO) fell below
10,000 for the first time (Simarro et al. 2011). However, many cases are
unreported due to various infrastructural reasons, and hence there could still be
many undetected or undiagnosed cases. There were estimated 12 undetected
deaths due to HAT for every one reported in Uganda in 2005 (Odiit et al. 2005).
Due to frequent travelling, 94 cases were also reported in non-endemic countries
in 2010 (Simmaro et al. 2000-2010). Hence, HAT still remains a major concern in
endemic as well as non-endemic countries.
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Figure 1-1: Trypanosome cells and its insect vector. (A) A blood smear of a
patient suffering from African trypanosomiasis. Trypanosome cells can be seen
in extracellular fluid. (From Myron G Schultz, Centers for Disease Control Public
Health Image Library) (B) A tsetse fly, the insect host of T. brucei. (From Anthony
Bannister, Encyclopedia Britannica).
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Symptoms, diagnosis and treatment
Blood-sucking infected tsetse flies bite humans leading to the onset of HAT. A
primary lesion is a painful swelling (Chancres) appearing after 10 to 15 days of
the initial bite. After the bite of a tsetse fly, trypanosome cells enter the
bloodstream, lymph nodes and several other organs, such as spleen, heart, liver,
eyes, and endocrine organs. This leads to the onset of heamolymphatic stage
also known as stage one (Kennedy, 2004 and Kennedy, 2013). Wide ranges of
symptoms are present such as headache, malaise, arthralgia, weight loss,
fatigue and fever. If left untreated, patients can suffer from lymphadenopathy,
cardiac failure, endocrine dysfunction, or fertility problems (Duggan and
Hutchington 1996, Atouguia and Kennedy 2000, Brun et al. 2010 and Kennedy,
2010). Trypanosome cells cross the blood-brain barrier in humans and invade
the brain after a few weeks of infection in the case of T. b. rhodesiense infection
or after several months in the case of T. b. gambinese infection. This is the late
stage of HAT known as the encephalitic stage or stage two (Kennedy, 2013).
Death could occur within few weeks in the case of T. b. rhodesiense infection.
This stage is characterized by the occurrence of meningoencephalitis, tremor,
abnormal movements, and speech impairment (Blum et al. 2006). Typical
symptom of this stage is alteration in the structure of sleep and reversal of the
normal sleep/wake cycle. Patient suffers from insomnia during the night and
uncontrollable episodes of sleep during the day; hence, the name ‘sleeping
sickness’ (Buguet et al. 2005). Untreated patients will deteriorate and eventually
die.
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Treatment of HAT depends on the stage of the disease. It is, therefore, vital
to establish whether the patient is suffering from an early or a late stage of
infection. T. b. rhodesiense infections are associated with high parasitemia and
can be easily detected by blood or lymph smears at the early stage (Kennedy,
2006). T. b. gambiense infections are harder to detect using a blood smear due
to low parasitemia levels. An antibody test has been developed called the card
agglutination Trypanosomiasis test (CATT) for detection of the parasite (Truc et
al. 2002). PCR has also been developed to detect the disease at its early stage.
However, the approach needs further development, as it cannot be utilized for
routine screening in the community (Mugasa et al. 2012). The late stage disease
is detected by analyzing the cerebrospinal fluid for the presence of trypanosomes
and/or elevated levels of white blood cells (WHO, 1998 and Kennedy, 2008).
Treatment of HAT has been unsatisfactory so far due to the lack of oral and
less toxic drugs. Current available drugs could also be ineffective at times
(Fairlamb, 2003).
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Table 1: Drugs used for treatment of human African trypanosomiasis (Kennedy,
2013). IV= intravenous, IM= intramuscular.
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Pentamidine is administered through an intramuscular route as a first line
treatment of T. b. gambiense infection (Atouguia and Kennedy, 2000, Brun et al.
2010). Life-threatening complications such as hyperglycemia, hypoglycemia,
hypotension, and gastrointestinal troubles arise upon administering this drug
(Atouguia and Kennedy, 2000, Kennedy, 2004, Brun et al. 2010). Intravenous
Suramin is administered to first stage patients with the T. b. rhodesiense
infection. Complications associated with the drug include renal failure,
anaphylactic shock, skin lesions, bone marrow toxicity, and neuropathy (Atouguia
and Kennedy, 2000, Kennedy, 2004, Brun et al. 2010). Trivalent organic
arsenical Melarsoprol is the only drug available for treatment of the late stage T.
b. rhodesiense infection. It acts on a parasite molecule called typanothione that
maintains an intracellular reducing environment (Fairlamb et al. 1989). Drug
resistance has been observed in Melarsoprol along with toxic side effects , such
as encephalopathy, skin rashes, peripheral neuropathy, and cardiac arrhythmia
(Legros et al. 1999, Kennedy, 2004, Brun et al. 2010). Eflornithine (an ornithine
decarboxylase inhibitor) is administered for the late-stage treatment of T. b.
gambiense infection (Burri and Brun 2003, Kenned y, 2008). Eflornithine has
many drawbacks such as bone marrow toxicity, seizures , and gastrointestinal
issues (Burri and Brun 2003, Kennedy, 2004). Hence, development of less toxic
and better medication is required for ultimate elimination of this disease.
Life cycle of T. brucei
The T. brucei is an obligate parasite and requires a host for its survival. It is
transmitted to the mammalian host via tsetse fly.
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Figure 1-2: Life cycle of the T. brucei. (A) Schematic representation of the T.
brucei life cycle (Dreesen et al. 2007). (B) An immunofluorescence image of a
bloodstream form T. brucei cell stained with VSG specific antibody (green). DAPI
staining depicts nucleus and kinetoplast. (C) High magnification electron
microscope image depicting surface coat protein of T. brucei (black arrow)
(Image was obtained from Rockefeller University Laboratory of Medical
Parasitology).
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Trypanosome parasites enter the mammalian host when an infected tsetse fly
bites the host. In the mammalian host, the bloodstream form (BF) T. brucei
expresses a dense layer of ~10 million surface coat protein molecules called
variant surface glycoproteins (VSG) (figure 1-2). These VSGs are rod shaped
molecules anchored to the membrane through a glycosylphosphatidylinositol
(GPI) anchor, and they cover the entire cell surface including the flagellum
(Ferguson, 1999, Schwede and Carrington, 2010). The parasite remains
extracellular and survives in the bloodstream of the host by evading its immune
response through periodically changing VSGs, a phenomenon termed antigenic
variation (McCulloch, 2004, Pays et al. 2004). These proliferative BF T. brucei
are morphologically slender and long; and eventually differentiated to a short and
stumpy form (Matthews et al. 2004). This serves two purposes: (1) the
parasitemia levels is controlled ensuring prolonged host survival and (2) the
stumpy form T. brucei cells uniformly arrest in the G1 phase, which allows them
to have coordinated morphological changes upon re-entry into the tsetse fly
(Matthews, 2005).
Upon re-entry into the tsetse fly, the stumpy form metamorphoses into a more
proliferative form called procyclic form (PF). At this stage all VSG genes are
silenced (Kooter and Borst, 1984, Kooter et al. 1987) and a different but a less
dense surface coat of procyclic acidic repetitive protein (PARP, also known as
Procyclin) is expressed (Roditi et al. 1989, Dorn et al. 1991, pays et al. 1993).
Procyclins, unlike VSGs, are resistant to tsetse fly gut proteases, allowing
parasite to survive in the gut of the insect host (Gruszynski et al. 2006). PF cells
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proliferate in the mid-gut of tsetse fly and eventually migrate towards the salivary
glands of the fly. They attach to the fly’s salivary glands by elaboration of the
flagellar membrane and become quiescent. This quiescent metacyclic form T.
brucei expresses a surface coat consisting of metacyclic VSGs (mVSGs).
Metacyclic form cells remain in the lumen of the salivary gland and are
transferred to a new mammalian host when the tsetse fly takes a bite of the host.
After infection mVSGs are silenced in the mammalian host and BF VSGs are
expressed. Expressing metacyclic VSG is important for parasite survival and
proliferation after T. brucei cells are transferred back into the mammalian host
(Vickerman, 1985).
Hence, the regulation of the expression of the life cycle stage-specific coat
protein as well as the silencing of the other surface coat is crucial for T. brucei
survival and pathogenesis. Elucidating the mechanism of this regulation is
important for understanding the pathogenesis of this parasite.
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Genome of T. brucei

Figure 1-3: Schematic representation of chromosomes of T. brucei. Sequencing
of intermediate chromosome is not yet complete, and hence the representation is
partially hypothetical (Ersfeld, 2011).
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The T. brucei genome consists of 11 pairs of megabase chromosomes, ~5
intermediate

chromosomes,

and

~100

minichromosomes

(figure

1 -3).

Intermediate chromosomes, and minichromosomes are usually haploid. The
sizes of diploid megabase chromosomes vary greatly, ranging from 5.5 Mbp
(chromosome XI) to 0.9 Mbp (chromosome I) (Berriman et al. 2005, Melville et al.
1998, Melville et al. 2000). Megabase chromosomes can be divided into two
large regions: (1) The chromosome internal core region consisting of
housekeeping genes transcribed by RNA polymerase II and (2) the subtelomeric
region consisting of VSG expression sites where VSG genes are transcribed by
RNA polymerase

I (Berriman et al. 2002, Hertz-Fowler et al. 2008).

Heterogeneity in the size of

megabase chromosomes is mostly due to the

subtelomeric chromosomal regions (Callejas et al. 2006). Not every megabase
chromosome and every telomere has the VSG expression site at the
subtelomeric region, resulting in these chromosomes being partially hemizygous
(Melville et al.1999).
There are approximately 9,000 predicted genes in the T. brucei genome
(Berriman et al. 2005). ~1,500 genes among them are VSG genes and they are
usually organized in large

subtelomeric arrays

(figure 1 -3, megabase

chromosomes) (Barry et al. 2005, Berrimen et al. 2005). Many of these genes
are VSG pseudogenes that are used by the parasite for assembling functional
mosaic genes through DNA recombination (Marcello and Barry, 2007). T. brucei
genes lacks introns and are transcribed in polycistronic transcription units (Mair
et al. 2000).
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There are ~5 intermediate chromosomes ranging in size from 200 to 900 Kbp
in each cell (Van der Ploeg et al. 1984a). They consist of non-repetitive DNA
cores, subtelomeric 177 bp repeats, and telomeric repeats (Wickstead et al.
2004). Few of the Intermediate chromosomes can also carry subtelomeric VSG
expression sites (Van der Ploeg et al. 1984b). Similar to the megabase
chromosome, not every intermediate chromosome carries ESs at their
subtelomeric loci.
The T. brucei genome consists of ~100 minichromosomes ranging in size
from 30 to 150 kbp; this comprises approximately 10% of the nuclear DNA
(Gibson and Borst, 1986, Van der Ploeg et al. 1984a). Minichromosomes consist
of palindromic 177 bp repeats in the core and non-repetitive elements including
VSG genes towards the telomeric ends (Weiden et al. 1991, Zomerdijk et al.
1992, Alsford et al. 2001, Wickstead et al. 2004). It is thought that the VSGs on
minichromosomes are never expressed. They serve as an important VSG
reservoir for VSG switching (Borst, 1986).
Surface molecules of T. brucei and their expression
T. brucei expresses different major surface coat proteins at various stages of
its life cycle. In the mammalian host, it expresses the bloodstream form VSGs. In
the mid-gut of the insect host, it expresses procyclins and all bloodstream form
VSGs are silent. After reaching the salivary glands of the fly, it changes its
surface coat and expresses metacyclic VSGs. All these coat proteins are
expressed from different sites (some being in specialized expression sites) on
chromosomes, and their expression is tightly regulated.
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Figure 1-4: Loci of VSGs and procyclin expression sites in T. brucei.
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In the bloodstream form, VSGs are exclusively expressed from the
subtelomeric bloodstream form VSG expression sites (ESs) (de Lange and Borst
1982). In total there are 15 different ESs present on the megabase and
intermediate chromosomes in the T. brucei 427 strain (Hertz-Fowler et al. 2008).
Along with VSG, ESs also consist of other genes known as Expression SiteAssociated Genes (ESAGs) (Pays et al. 2001) and a stretch of repeats with TAArich sequence known as 70-bp repeats. VSG is located at the end of the ES and
next to the telomeres. These expression sites are polycistronically transcribed by
RNA polymerase I, and the promoter is located 40-60 kb upstream of the VSG
gene (Gunzl et al. 2003, Hertz-Fowler et al. 2008). Only one ES promoter is fully
active, resulting in a single type of VSG being expressed and present on the
surface of the trypanosome cell. The silent archives of VSGs are present in long
tandem arrays on the megabase chromosomes or as a single gene on the
minichromosomes. These VSGs can only be expressed after they are
recombined into the active ES (Horn and Barry 2005).
When T. brucei cells are in the metacyclic form, metacyclic VSGs (mVSGs)
are expressed from metacyclic VSG expression sites (MESs) located on a few of
the megabase chromosomes. MESs are monocistronic transcription units located
at subtelomeres with the promoter being located ~5 kb upstream of the telomeres
(Lenardo et al. 1984, Cornelissan et al. 1985, Alarcon et al. 1994). MESs are
also transcribed by RNA polymerase I (Ginger et al. 2002). The VSG genes in
these sites are rarely replaced. The parasite population injected into the
mammalian host expresses many different mVSGs; however, each cell
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expresses only one type of mVSG (Tetley et al. 1987). This diversity in the
population allows the parasite to easily establish successful infection in the
mammalian host (Barry et al. 1998).
Unlike VSGs, procyclin is expressed from a chromosomal-internal locus.
Procyclin genes are organized in tandem arrays of two or three copies on two
pairs of megabase chromosomes (Mowatt and Clayton, 1987, Koenig et al.
1989). In total there are four types of loci expressing procyclins (Ruepp et al.
1997). Three of these loci express proteins with extensive glutamic acid-proline
dipeptide repeats (EP repeats) and can be distinguished by a presence or an
absence of glycosylation sites, while the fourth type of locus encodes proteins
with pentapeptide repeat (GPEET) and no glycosylation site (Roditi et al. 1998).
Similar to VSGs and mVSGSs, procyclins are also transcribed by RNA
polymerase I (Gunzl et al. 2003). However, in contrast to ESs and MESs,
procyclins can be simultaneously expressed from two or more loci (Mowatt and
Clayton, 1987, Mowatt and Clayton, 1988).
In the mammalian host, T. brucei is able to evade the attack from the host
immune system through regular switching of VSG through a phenomenon called
antigenic variation. Antigenic variation allows the parasite to establish persistent
infection in the host.
Antigenic variation in T. brucei and its regulation
Antigenic variation comprises of two main aspects:
(1) VSG switching – This involves periodic switching of the expressed VSG and
changing the surface coat to an immunologically distinct VSG.
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(2) Monoallelic VSG expression – VSGs are exclusively expressed from only one
of the 15 ESs while the rest are kept silent. This monoallelic expression ensures
effective VSG switching and provides the parasite with an inexhaustible reservoir
of surface molecules when challenged by the host’s immune system.
T. brucei megabase chromosomes carry a large array of VSG genes located
at the subtelomeres. Minichromosomes also carry VSGs at their subtelomeric
loci. All these silent VSGs serve as a reservoir for antigenic variation (Marcello
and Barry, 2007). Activation of these VSGs occurs primarily through
recombination into the ESs located on the megabase chromosomes. There are
fundamentally two main mechanisms used during VSG switching: (a) a
transcriptional switch and (b) recombination (reviewed in Horn and McCulloch,
2010 and Rudenko, 2011).
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Figure 1-5: Mechanism of VSG switching in T. brucei. Two main mechanisms of
VSG switching are schematically depicted. Different color rectangular boxes
depict different VSGs (figure adapted from Horn and McCulloch, 2010).
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As seen in figure 1-5, during transcriptional switching, a new ES is expressed
and the originally acti ve ES is silenced. Another mechanism involves DNA
recombination, which primarily occurs through a gene conversion process (Barry
and McCulloch, 2001). During the duplicative VSG gene conversion process, a
silent VSG, usually from a silent ES, is duplicated and copied into the active ES
by replacing the old VSG gene (which is lost). Another mechanism is ES gene
conversion, where an entire ES is copied into the active ES resulting in its
duplication and loss of the previously active ES. Switching can also occur
through crossovers where VSG crossover occurs between two telomeric ends
carrying VSG genes, resulting in a new VSG gene (present on minichromosomes
or a silent ES) inserted into the active ES. Such crossovers may or may not
include telomeric sequences. Finally, a less frequent process can generate a
novel mosaic VSG gene in the active ES. This is achieved by copying the
sequence from multiple VSGs genes that are normally nonfunctional (Kamper
and Barbet, 1992). Such a mechanism is thought to be important for maintaining
a persistent late-stage infection.
Many factors regulating VSG switching have been identified. DNA damage
repair factors BRCA2, RAD51, and its paralogue RAD51-3 have been shown to
affect the VSG switching frequency. Knockout cells for these factors displayed
lower switching frequencies (McCulloch and Barry, 1999, Proudfoot and
McCulloch, 2005, Hartley and McCulloch, 2008, Dobson et al. 2011). On the
contrary, deletion of the factors, such as TOPO3α topoisomerase and RMI1
(usually involved in DNA recombination) led to an increased VSG switching
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frequencies (Kim and Cross, 2010, Kim and Cross, 2011). The cohesin subunit
SCC1 was shown to be required for faithful inheritance of the active VSG to the
daughter cell and its depletion led to an increase in the VSG switching frequency
(Landeira et al. 2009). Depletion of the DNA replication factor ORC1 (origin
recognition

complex)

displayed

an

elevated

VSG switching

frequency

(Benmerzouga et al. 2013). Finally, telomeres play an important role in regulating
the VSG switching. Telomerase reverse trancriptase (TERT) null cells carrying
extremely short telomeres had a higher VSG switching frequency, where most
VSG switchers arose through gene conversion events (Hovel-Miner et al. 2012).
Also, the depletion of telomeric proteins, such as TbTRF (Jehi et al., reviewed
and currently in revision), TbRAP1 (Nanavaty and Li, unpublished data), and
TbTIF2 (Jehi et al. 2014) affect the VSG switching frequencies.
For a successful VSG switching, it is extremely important to have a tightly
regulated monoallelic VSG expression.
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Figure 1-6: Monoallelic expression of VSG in T. brucei. Multiple ESs carrying
different VSGs are depicted.
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Only one ES is fully active at any time in a T. brucei cell (Cross, 1975).
Although transcription initiates at all ES promoters, only one promoter is fully
active, resulting in a single type of VSG being expressed. Multiple mechanisms
have been identified that play roles in regulating monoallelic VSG expression: (1)
restricted transcription elongation, (2) a unique subnuclear locus for VSG
transcription, (3) chromatin remodeling, (4) replication machinery, and (5)
telomeric silencing.
Transcription initiates at multiple ES promoters, but transcription elongation
quickly attenuates in all but one ES, resulting in only one ES being fully
transcribed. This is proposed to happen due to selective recruitment of the RNA
elongation/processing machinery (Vanhamme et al. 2000). Another interesting
feature observed in T. brucei is the presence of an extranucleolar polymerase I
containing focus. It has been determined that only the active ES is associated
with this extranucleolar focus called ES body (ESB) (Navarro and Gull, 2001). An
ESB is required for stable inheritance of the active VSG, thus suggesting its role
in the monoallelic expression (Landeira et al. 2009).
The chromatin structure has been shown to play an important role in
regulating ES transcription. It was determined that silent ESs have regularly
spaced nucleosomes while the active ES is highly devoid of nucleosomes
(Figueiredo and Cross, 2010, Stanne and Rudenko, 2010). However, it still
needs to be determined whether such nucleosome occupancy in the active ES is
a cause or a consequence of RNA polymerase I transcription. Many chromatinremodeling factors have been identified that affect ES promoter activities. The
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depletion of histone H3 (Alsford and Horn, 2012), linker histone H1 (Povelones et
al. 2012), and histone chaperones, such as FACT (Denninger et al. 2010), NLP
(Narayanan et al. 2011), and ASF1A or CAF-1b (Alsford and Horn, 2012) led to
the derepression of the silent ES promoter without affecting VSG silencing.
Similar effects on the ES promoter were also observed upon the depletion of
chromatin remodeler ISWI (Stanne et al. 2011). Depletion of SIR2rp1 (homolog
of yeast Sir2) (Alsford et al. 2007), MYST-family histone acetyltransferase HAT1
(Kawahara et al. 2008), and histone deacetylase DAC1 or DAC3 (Wang et al.
2010) led to the derepression of telomere proximal reporter genes without
affecting VSG silencing. Interestingly, depletion of the histone methyltransferase
DOT1B led to an ~10 fold derepression of the silent VSGs suggesting that it is
required for monoallelic VSG transcription (Figueiredo et al. 2008).
The DNA replication machinery is suggested to have a link with antigenic
variation in T. brucei. The depletion of ORC1 (origin recognition complex) led to a
4-12 fold derepression of the silent VSGs (Benmerzouga et al. 2013). The
knockdown of MCM-BP (MCM binding protein, a component of replication
complex) also led to a 12-30-fold derepression of silent VSGs (Kim et al. 2013).
However, the detailed mechanisms are unknown.
Finally and most importantly, telomeres have been shown to play important
roles in maintaining VSG silencing. TbRAP1, a telomeric protein, is known to be
important for maintaining VSG silencing. Depletion of TbRAP1 led to a 10-100fold derepression of all the silent VSGs tested (Yang et al. 2009). Such high
derepression is not observed when other factors were examined, suggesting that
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telomeres are crucial in VSG expression regulation. Our lab focuses on
characterizing and elucidating functions of telomere in antigenic variation of T.
brucei.
Telomeres and the telomere complex
Telomeres are the ends of linear chromosomes. They contain telomeric DNA
and telomere-associated proteins. Telomeric DNA consist of G-rich repetitive
sequences, such as TG2-3(TG)1-6 in budding yeast, TTACAG2-5 in fission yeast,
TTTAGGG in plants and, TTAGGG in humans (Shampay et al. 1984, Sugawara
et al. 1986, Moyzis et al. 1988, McKnight et al. 1997). Most of the telomere DNA
is duplex except for a single-stranded 3’-overhang present at the end of
telomeres known as G-overhang. Protein-free DNA ends are susceptible to
degradation by nucleases and illegitimate repair by DNA damage repair
machineries, which leads to genome instability. Telomeric proteins form a
protective cap and ensure chromosome stability and genome integrity. Linear
DNA molecules require additional mechanisms to complete the replication of
their extreme termini. Attrition of sequences from the ends of chromosomes
occurs after every round of semi-conservative DNA replication. This is known as
the end replication problem. Without alternative mechanism such attrition would
lead to loss of genetic information and prevent cells from multiplying. This end
replication problem is solved by telomerase (Greider and Blackburn 1985).
Telomerase is a ribonucleoprotein complex with a reverse transcriptase activity
that can synthesize telomeric DNA de novo, and solve the telomere end
replication problem.
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Figure 1-7: Telomere complexes in different organisms. Core components of
telomere complex identified so far along with telomerase in budding yeast,
mammals, and T. brucei are depicted.
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Telomeric DNA in budding yeast consists of a G-rich imperfect repeat
sequence, such as TG2-3(TG)1-6 (Shampay et al. 1984). The distal end of
telomeres contains G-rich 3’ single-stranded overhang called G-overhang
(McElligott and Wellinger, 1997, Klobutcher et al. 1981, Shampay et al. 1984,
Moyzis et al. 1988). ScRAP1 is a component of the budding yeast telomere
complex and is the predominant duplex telomere DNA binding factor (Konig et al.
1996). ScRAP1 interacts with two groups of telomeric proteins. One group
consisting of ScRif1 and ScRif2 is primarily involved in telomere length regulation
(Hardy et al. 1992, Wotton and Shore, 1997). The other group consists of Sir3
and Sir4 and is primarily involved in heterochromatin formation/maintenance and
silencing of subtelomeric gene transcription (Moretti et al. 1994, Cockell et al.
1995). Sir3 and Sir4 recruits Sir2, which deacetylates histones on neighboring
nucleosomes and provides further binding sites for Sir3 and Sir4, thereby
allowing propagation of heterochromatic structure (Rusche et al. 2002). Cdc13
binds to the single-stranded G-overhang along with two other factors called Stn1
and Ten1, and mutations in this complex lead to abnormally elongated or
shortened telomeres (Nugent et al. 1996, Grandin et al. 1997, Grandin et al.
2001). The Ku heterodimer, consisting of yku70 and yku80 subunits, binds to the
distal end of the telomeres and is known to be important for regulating telomere
length and silencing (Boulton and Jackson 1998, Gravel et al. 1998, Polotnianka
et al. 1998). Finally, telomeres in budding yeast are maintained by telomerase,
consisting of Tlc1 (the RNA subunit of telomerase), Est2 (the catalytic protein
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subunit of telomerase), Est1, and Est3 (Singer and Gottschling 1994, Zhou et al.
2000,Timothy et al. 2000).
The human telomeric DNA consists of TTAGGG repeats (Moyzis et al. 1988).
The core telomere protein complex in humans is known as the Shelterin and
consists of six subunits. TRF1 and TRF2 bind directly to the duplex telomeric
DNA as homodimers (Broccoli et al. 1997). Overexpression of a dominant
negative mutant of TRF1 leads to removal of TRF1 from the telomere and
abnormally elongated telomeres. Overexpression of a dominant negative mutant
of TRF2 leads to removal of TRF2 from the telomere and chromosome end
fusions (Van Steensel and de Lange 1997, Van Steensel et al. 1998). It has been
shown that human telomeres fold back and the single stranded telomere Goverhang invade the double stranded telomeric DNA region to form a lasso-like
structure, known as the T-loop (Griffith et al. 1999). TRF2 is required for the
formation and/or maintenance of the T-loop (Dokasani et al. 2013). TIN2 is
localized to telomeres through interaction with both TRF1 and TRF2, and its
truncation leads to abnormally elongated telomeres (Kim et al. 1999). RAP1 was
identified as a TRF2-interacting factor, and overexpression of RAP1 or some
domain deletion mutants leads to elongation of telomeres (Li et al. 2000, Li and
de Lange 2003). POT1 is another component of Shelterin and binds to the
single-stranded telomeric DNA (Lei et al. 2002, Loayza and de Lange 2004, Lei
et al. 2004). POT1 protects telomere ends from nucleolytic degradation and also
regulates telomerase-dependent telomere elongation (Loayza and de Lange
2003, Liu et al. 2004, Hockemeyer et al. 2005, Yang et al. 2005). Recent work
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also showed that POT1 protects the telomere by preventing RPA-mediated
activation of the ATR signaling pathway (Denchi and de Lange 2007). TPP1
interacts with POT1 and is required for the telomere localization of POT1 (Liu et
al. 2004). TPP1 binds to POT1 and increases its affinity for telomeric ssDNA. It
also interacts with the telomerase for its recruitment to telomeres (Xin et al. 2007,
Wang et al. 2007). The Ku heterodimer is known to bind DNA ends i n a
sequence independent manner and is a key player in the Non-homologous end
joining pathway (NHEJ). At telomeres, the Ku70/Ku80 heterodimer is known to
interact with TRF1 or TRF2 and prevent end joining (Hsu and Gilley 2000, Song
et al. 2000). The telomerase consists of a protein subunit called TERT and its
RNA component called TERC (Nakamura et al. 1997). However, these are just
minimal components and additional accessory factors are required for its function
in vivo. Other telomerase-associated factors include hEST1A, hEST1B, and
dyskerin (Mitchell et al. 1999, Reichenbach et al. 2003, Snow et al. 2003).
The T. brucei telomere sequence is the same as the one for the vertebrate
telomere and consists of TTAGGG repeats (Blackburn and Challoner 1984). The
T. brucei telomere can be more than 10 kb long and comprises 10% of the total
DNA (Dreesen and Cross 2008). Similar to human telomeres, but comparatively
much smaller (~1 kb), t-loops have been observed in T. brucei (Munoz-Jordan et
al. 2001). At the end of the telomeres there is a short single stranded 3’ G-rich
overhang. TbTRF is a component of the core telomere complex, and it directly
binds to the duplex telomere DNA (Li et al. 2005). TbTRF is required for telomere
end protection, and its depletion leads to loss of the telomere G-overhang
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structure (Li et al. 2005). TbRAP1 was identified as a TbTRF-interacting factor
and it plays an important role in regulating VSG silencing at T. brucei telomeres
(Yang et al. 2009). TbTIF2 (TRF interacting factor) was recently identified as a
component of the telomere complex, and it is required for maintaining
subtelomere/telomere integrity and stability. Depletion of TbTIF2 leads to an
increased VSG switching frequency (Jehi et al. 2014). TbTRF and TbRAP1 also
play roles in regulating VSG switching in T. brucei (Jehi et al., reviewed and
currently in revision, Nanavaty and Li, unpublished data). Ku80 has been
characterized in T. brucei, and it is required for telomere length maintenance as
its deletion leads to telomere shortening (Conway et al. 2002, Janzen et al.
2004). The telomerase complex in T. brucei consists of a protein subunit called
TbTERT and an RNA component called TbTR (Cano et al. 1999, Dreesen et al.
2005, Sandhu et al. 2013, Gupta et al. 2013). Deletion of TbTERT and TbTR
leads to the shortening of telomeres. This shortening of telomeres led to an
increased VSG switching frequency (Dreesen and Cross, 2006, Hovel-Miner et
al. 2012, Sandhu et al. 2013).
Recent studies have shown that the T. brucei telomeres and its integral
components play a key role in regulating antigenic variation (VSG silencing and
VSG switching). Hence, it is crucial to understand the telomere biology and
elucidate its role in pathogenesis of T. brucei.
Telomere transcription and heterochromatin formation
Long non-coding RNAs are involved in epigenetic regulation of gene
expression by either forming euchromatic or heterochromatic structures.
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Chromatin associated long non-coding RNAs, such as XIST and rox regulate
dosage compensation in mammals and Drosophila melanogaster, respectively
(Deng and Meller, 2006, Payer and Lee, 2008). Air or Kcnq1ot1 are long noncoding RNAs involved in genomic imprinting (Pauler et al. 2007, Pandey et al.
2008). Hence, it is increasingly evident that long non-coding RNAs play important
roles in epigenetic regulation of gene transcription.
Contrary to popular belief that telomeres are transcriptionally silent due to
their repressive chromatin state, it has been established that telomeres are
transcriptionally active and produce long non-coding RNA molecules called
TERRA (telomere repeat containing RNA) (Azzalin et al. 2007, Schoeftner and
Blasco, 2008). TERRA ranges in size from 100 bp to 9 kb in mammals and is
transcribed from the C-rich strand giving rise to UUAGGG repeats (Azzalin et al.
2007, Schoeftner and Blasco, 2008). TERRA forms discrete nuclear foci and is
associated with telomeres in vivo (Azzalin et al. 2007). It is known to interact with
the telomeric proteins TRF1 and TRF2 (Deng et al. 2009).
Not all TERRA foci are colocalized with telomeres. Interestingly, in mouse
embryonic fibroblasts, an intense TERRA focus co-localizes with XIST RNA that
coat inactive X chromosomes (Schoeftner and Blasco, 2008).

Also, TERRA

associates with mouse sex chromosomes in a development specific manner.
Upon development, it is only associated with telomeres of heterochromatinzed
(inactive) sex chromosome of each sex (Ogawa et al. 2008). This suggests that
the possible role of TERRA is to establish/maintain heterochromatin at inactive
sex chromosomes.
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Open chromatin structure favors transcription of TERRA. TERRA levels are
increased when human cells are treated with an inhibitor of Class I and II histone
deacetylases (Azzalin et al. 2007). Mouse cell lines deficient in histone
methyltransferases Suv3-9h and Suv4-20h also displayed elevated levels of
TERRA (Schoeftner and Blasco 2008). On the contrary, the knock-out of
telomerase RNA component in mouse cells led to shortened telomere sand
decreased levels of TERRA (Schoeftner and Blasco 2008). These shortened
telomeres also had an open chromatin structures with decreased levels of
telomeric histone methylation and increased histone acetylation (Benetti et al.
2007). In addition, overexpression of TRF2 in mouse cells led to the telomere
shortening with an open chromatin structure but with decreased levels of TERRA
(Benetti et al. 2008). Hence, TERRA levels are intricately balanced in vivo, and
the telomere length can affect TERRA levels.
Not much is known about functions of TERRA. SiRNA mediated depletion of
TERRA affected cell viability, telomere aberratio ns, decreased recruitment of
ORC to telomeres, and decreased H3K9 trimethylation at telomeres in human
cells (Deng et al. 2009). TERRA is known to facilitate ORC recruitment to
telomeres via binding to TRF2 (Deng et al. 2009). These results collectively
suggest that TERRA may play a role in forming the heterochromatin structure at
telomeres.
TERRA is also proposed to negatively regulate telomerase -mediated telomere
elongation (Schoeftner and Blasco 2008). Telomerase-positive cells display
higher methylation of TERRA promoters and lower level of TERRA compared to
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telomerase-negative cell lines (Ng et al. 2009). Also, high-grade tumors have
diminished levels of TERRA compared to low-grade tumors (Schoeftner and
Blasco 2008). During embryonic development of mouse, high telomerase activity
is related to lower levels of TERRA (Schoeftner and Blasco, 2008). Finally,
TERRA was shown to efficiently inhibit telomerase in vitro by base pairing with
the RNA component of telomerase (Schoeftner and Blasco, 2008). On the
contrary, a recent study in budding yeast showed that TERRA nucleates
telomerase molecules and recruits them specifically to short telomeres for their
elongation (Cusanelli et al. 2013). Thus, more research needs to be done in
order to determine the role of TERRA in regulating telomerase activity.
It is critical to regulate TERRA levels in the cell. The impairment of non-sensemediated RNA decay machinery in human cells or the deletion of 5’-3’
exonuclease Rat1p in budding yeast interferes with the decay of TERRA
molecules and leads to its eventual accumulation (Azzalin et al. 2007, Luke et al.
2008). These elevated levels of TERRA led to the dramatic shortening of
telomere tracts by rapid truncations (Azzalin et al. 2007, Luke et al. 2008).
Forced transcription of yeast telomeres led to the shortening of its telomeric
tracts (Sandell et al. 1994). Using transcriptionally induced telomeres, it was
proven that high levels of TERRA lead to telomere shortening in a DNAreplication dependent manner and also cellular senescence in the absence of
telomere maintenance mechanisms (Maicher et al. 2012). TERRA forms RNADNA hybrids with telomeric DNA and their accumulation promotes telomeric
recombination (Balk et al. 2013). Collectively, these results suggest that it is
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extremely important to regulate TERRA levels in cells as it can lead to an early
senescence and a deleterious effect. However, deregulating TERRA transcription
can be beneficial when fighting against pathogens such as T. brucei.
TERRA has been identified in T. brucei; however, nothing is known about its
function or regulation (Rudenko and Ploeg 1989). It ranges in size from ~200 bp
to 9 kb and is transcribed by polymerase insensitive to α-aminitin treatment
(Rudenko and Ploeg 1989). From the results mentioned above, it is likely that
TERRA plays a role in forming a heterochromatic structure at telomeres and also
regulates telomere length and recombination in T. brucei. Hence, it will be
imperative to determine the functions of TERRA in regulating VSG silencing at T.
brucei telomeres. Due to its role in suppressing telomere recombination, it can be
hypothesized that TERRA may additionally regulate VSG switching in T. brucei.

Significance of the study
The T. brucei undergoes antigenic variation and evades host immune
responses. Genes encoding its surface antigen are located at subtelomeric loci ,
and it is proven that telomeres play important roles in the regulation of VSG
expression. Importantly, telomeric proteins of T. brucei, although functionally
conserved, have very low sequence homology with the human telomeric
proteins. This makes telomeric proteins potential drug targets for therapeutic
purposes, as they are essential for survival of the parasite. Understanding the
functions of telomeres in regulating antigenic variation will provide means to
disrupt its regulation. Disruption of antigenic variation will facilitate the host’s
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immune system to combat T. brucei infection. In addition, since telomere proteins
are essential for the survival of the parasite; targeting these telomere proteins will
have deleterious effects.
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CHAPTER II
MATERIAL AND METHODS

Growth analysis
Uninduced and induced cells were grown in parallel to compare their growth.
Cells were counted at regular intervals and population doublings was calculated.
Population doubling = log2 (total number of cell, n/total number cells, (n-1)) + PD
(n-1), where n is the hour or day when cells are counted and n-1 is the immediate
time-point preceding it.
Western blot analysis
Cells were lysed in 2X laemmli buffer (0.1 M Tris-Cl, pH 6.8, 6% SDS, 20%
glycerol, 0.004% bromophenol blue) and boiled at 100ºC for ten minutes in order
to collect total cell lysate (Laemmli 1970). Samples were separated on 6-10%
Tris-Glycine polyacrylamide gel at 100 V for ~2 hours. After separation, proteins
were transferred onto 0.45 µm nitrocellulose membrane (GE healthcare life
sciences) by electrophoresis at 70 V for 2 hours at 4ºC. The membrane was
stained with Ponseau dye (2% w/v Ponseau S in 30% w/v Tri-chloroacetic acid)

36

for about a minute and rinsed with Ponseau destaining buffer (2.3 liters of ddH20
+ 4ml of concentrated HCl) to ensure proper transfer of proteins. The membrane
was blocked with 10% milk/ 0.5% Tween20/ 1x PBS (phosphate -buffer saline) at
room temperature for ~1 hour. The membrane was rinsed twice for ~5 minutes
each using 0.1% milk/0.1% Tween 20/ 1x PBS. The membrane was hybridized
overnight in a plastic bag using appropriate primary antibody and dilution, in
5%milk/ 0.1% Tween 20/ 1x PBS. Next day, the membrane was washed twice for
~5 minutes using 0.1% milk/ 0.1% Tween 20/ 1x PBS and hybridized wit h
appropriate secondary antibody in 5%milk/ 0.1% Tween 20/ 1x PBS at room
temperature for one hour. Followed by hybridization membrane was washed 4
times for ~5 minutes each using 0.1% milk/ 0.1% Tween 20/ 1x PBS. Final wash
was given for 5 minutes using 1 x PBS. Membrane was rinsed with water and
incubated with Amersham ECL western blotting reagent (GE Healthcare Life
Sciences) for ~2 minutes. The blot was exposed to X-ray films for various lengths
of time and the films were developed.
For detection of endogenous TbRAP1 protein, rabbit polyclonal antibodies
597 or 598 were used (Yang et al. 2009). Rabbit polyclonal antibodies 1260 or
1261 were used to detect TbTRF (Li et al. 2005). TAT-1 (gift from Dr. keith Gull)
was used to detect tubulin. A commercially available goat antibody against EF-2
(elongation factor 2) (Santa Cruz Biotechnology Inc.) was used. Rabbit antiVSG2 (CRD-depleted) antibody was used to detect VSG2 (Figueiredo et al.
2008). BB2 antibody (MSKCC, AB core facility) was used to detect Ty1-TbRAP1.
Rabbit GFP antibody was used to detect GFP tagged TbTRF, TbKU80, and
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hygromycin-GFP-TK. Commercially available HA antibody (F-7) (Santa Cruz
Biotechnology Inc.) was used to detect F2H (Flag-HA-HA) tagged TbRAP1 and
TbTIF2. Rabbit polyclonal antibody was used to detect histone H3 (AbCam).
Histone H2A was detected using a rabbit polyclonal antibody (Millipore
Corporation).
Southern blot analysis
Genomic DNA was isolated either using DNAzol (Life Science Inc.) or the
DNA spooling method (de Lange et al. 1990). The DNA concentration was
measured using NanoDrop 2000 (Thermo Fisher Scientific Inc.). 2-5 µg of
digested genomic DNA (using appropriate restriction enzymes) were separated
on a 0.7% agarose gel prepared in 0.5xTAE at 100 V until the orange G dye
reaches the bottom of the gel. The gel was scanned on Typhoon FLA 9140 (GE
Healthcare Life Sciences) by placing a ruler next to it. DNA was depurinated
(0.25 M HCL) for 30 minutes followed by denaturation (1.5 M NaCl; 0.5 M NaOH)
for one hour (buffer was changed after 30 minutes). Finally the DNA was
neutralized (1 M Tris 7.4; 1.5 M NaCl) for one hour and blotted onto hybond
nylon membrane (GE healthcare life sciences) in 20x SSC (3 M NaCl, 0.3 M
sodium citrate). After overnight blotting, the membrane was cross-linked
(Stratalinker UV crosslinker) and pre-hybridized for ~1 hour in CHURCH mix (0.5
M NaPi pH 7.2, 4 mM EDTA pH 8.0, 7% SDS, 1% BSA) at 65ºC. Hybridization
was done at 65ºC overnight using the CHURCH mix and appropriate
radiolabeled probe. The blot was washed three times using CHURCH wash (40
mM NaPi pH 7.2, 1 mM EDTA pH 8.0, 1% SDS) for ~15 minutes each at 65ºC,
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wrapped, and exposed to a phosphorimager screen (GE Healthcare Life
Sciences).
Probe labeling
For labeling of the probe, a desired DNA fragment of around 600-800 bp was
generated. 200 ng of this DNA fragment was mixed with 5 ng of random hexamer
and the total volume was brought up to 39 µl with double distilled water. The
mixture was incubated at 100ºC for 5 minutes and immediately moved on ice
after boiling. 5 µl of 10X nucleotide mixture (containing dATP, dGTP, dTTP)
without dCTP was added to the tube. Klenow polymerase (New England Biolabs)
and 5 µl of
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P-alpha-dCTP (3000 Ci/mmol) were added. The reaction was

incubated at room temperature for 90 minutes followed by adding 50 µl of TNES
(10 mM Tris pH7.4, 10 mM EDTA, 100 mM NaCl, 1%SDS) buffer. The probe was
purified on a 3 ml of G-50 beads column and eluted using TNES buffer. After
monitoring with a Geiger counter, the probe was heated at 100ºC for 5 minutes
and added to 10-25 ml of CHURCH mix. This mixture was filtered using a 0.22
µm syringe filter and added directly onto the blot.
End labeling of oligonucleotide probe was done for telomere in-gel
hybridization. 50 ng of TELC4 oligo ((CCCTAA)4) or TELG4 oligo ((TTAGGG)4)
was mixed with 32P-gamma-ATP, Kinase buffer, and Polynucleotide kinase (New
England Biolabs). The reaction was incubated at 37ºC for 45 minutes followed by
adding 80 µl of TES (Tris-HCl/EDTA/SDS) buffer to the mixture. The probe was
purified using a 3 ml Sepharose G-25 column and elution with TNES buffer. The

39

purified probe was mixed with 25 ml of CHURCH mix, filtered through a 0.22 µm
syringe filter, and added to the blot for hybridization.
RNA collection
Total RNA was isolated from T. brucei cells using RNAstat (TEL-TEST, Inc).
Briefly, 140 million cells were harvested by centrifugation at 580 g for 10 minutes
at 4ºC. The pellet was resuspended and evenly homogenized in 1 ml of RNAstat
reagent. After incubation at room temperature for 5 minutes, 200 µl of chloroform
was added to the tube and mixed vigorously by vortexing for 15-30 seconds.
After another 5 min incubation, the sample was centrifuged at 15,682 g for 15
minutes at 4ºC to collect the aqueous phase. 600 µl of isopropanol was added to
the aqueous phase and mixed thoroughly. Samples were stored at -20ºC. When
ready to use, samples were centrifuged at 15,682g for 15 minutes at 4ºC. The
RNA pellet was washed with 70% ethanol, air-dried, and dissolved using ddH2 O.
Reverse transcription and quantitative Real time PCR
RNA samples were cleaned using QIAGEN RNeasy kit and treated with
DNase (QIAGEN). Reverse transcription was performed using M-MLV (Promega)
according to the manufacturer’s protocol. Quantitative RT-PCR was carried out
using Bio-Rad iTaq SYBR Green supermix with ROX according to t he
manufacturer’s protocol. The amount of DNA was quantified using DNA Engine
Opticon 2 (Bio-Rad). The following formula was used to calculate normalized
increase in mRNA levels: (mRNA V , n/mRNAV , 0)/(mRNAT, n / mRNAT, o), where
mRNAV , n represents mRNA level for particular VSG at n hour after induction and
mRNAV , 0 represents mRNA levels at 0 hour. mRNA T,
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n

and mRNA T, o represent

the mRNA levels for β-tubulin at 0 hour (pre-induction) and n hours (postinduction).
Flow cytometry
~20 million cells were harvested by centrifugation at 208 g for 10 minutes at
4ºC. Cells were washed twice with 1xPBS/2 mM EDTA for PF cells or with
1xTDB (5 mM KCl, 80 mM NaCl, 1 mM MgSO4, 20 mM Na2HPO4, 2 mM
NaH2PO4, 20 mM glucose pH 7.4 ), with 2 mM EDTA for BF cells. Cells were
resuspended in 200 µl of 1xPBS/2mM EDTA (for PF cells) or in 1xTDB/2mM
EDTA (for BF cells). Cells were fixed by adding 2 ml of ice-cold 70% ethanol drop
wise while vortexing. After fixing, cells were stored for at least overnight at 4ºC.
Storage never exceeded more than one week. For performing FACS analysis,
cells were harvested by centrifugation at 208 g for 10 minutes at 4ºC. The cell
pellet was resuspended in 0.5 ml of staining solution (1xPBS, 2mM EDTA, 200
µg/ml RNAse A and 50 µg/ml propidium iodide). Cells were collected in a tube by
passing them through a cell-strainer cap and incubated in dark at 37ºC for 30
minutes. FACS was performed on BD FACSCanto II cytometer (BD Biosciences)
using the BD FACS DIVA software (BD Biosciences). Data were analyzed using
the FlowJo software.
Chromatin Immunoprecipitation (ChIP)
Dynabead protein G beads (Life Sciences Inc.) were prepared for the
immunoprecipitation. 50 µl of beads were washed and resuspended in 200 µl of
antibody binding and washing buffer (1xPBS, 0.02% Tween 20) with appropriate
antibody. Pre-immune serum of equal amount was used for a negative control.

41

Beads were kept for antibody coupling at 4ºC on a rotor. 2x10 8 cells were
harvested by centrifugation at 580 g for 10 minutes at 4ºC. Cells were
resuspended in 40 ml 1xTDB with proper mixing. Cells were fixed for precisely 20
minutes by adding 4 ml of freshly prepared 11% formaldehyde solution (final
concentration 1%). After fixing, 2.75 ml of 2M glycine was added to quench
formaldehyde. Cells were centrifuged at 5,000 g for 15 minutes at 4ºC. After
discarding supernatant cells were washed with cold 1xPBS. Cells were lysed
using lysis buffer containing appropriate protease inhibitors and sonicated using
sonic dismembrator (Thermo Fisher Scientific Inc.) at out put ~6 (Scale 4 -5) for 4
cycles with 30 second on/ 30 second off for each cycle. After taking out sample
to check sonication efficiency, 50 µl of 10% Triton-X100 was added to the tubes
and centrifuged at 15,682 g for 10 minutes at 4ºC. After centrifugation the
supernatant was carefully transferred to a fresh tube. 50 µl of sample was taken
out for Input from each tube. Beads were prepared for binding by placing them
on magnetic rack and removing the supernatant. The remaining lysate was
equally divided among the control tube (pre-immune serum) and the IP
(containing antibody) tube. Tubes were rotated at 4ºC for three hours. After
incubation, beads were thoroughly washed three times using 1xPBS and
samples were eluted using elution buffer (50 mM Tris-HCl, pH8.0, 10 mM EDTA
and 1% Sodium-dodecyl-sulphate). All samples (including input sample) were
reverse crosslinked using 5 µl of 5 M Nacl at 65ºC overnight. DNA was extracted
by phenol chloroform and purified using the Qiaquick spin PCR purification kit

42

(Qiagen). Quantitative PCR was performed using appropriate dilutions o f the
DNA.
10 µg of 598 antibody (rabbit polyclonal) was used for testing differential
binding of TbRAP1 to active and silent VSGs. 10 µg of 598 pre-immune serum
was used for a negative control. 5 µg of 1260 or 1261 antibody (rabbit polyclonal)
was used for testing differential binding of TbTRF to the active and silent VSGs.
Pull-down of specific DNA was calculated as percentage of input. The
following formula was used for calculation after performing quantitative PCR.
% of input = (1 + Efficiency)

ΔCT

/ (dilution factor) * 100

where ΔCT (sample) = ΔCT (untreated sample) - ΔCT (treated sample)
In this case, treated samples were either preimmune control or IP sample.
Untreated sample represents input.
Formaldehyde assisted isolation of regulatory elements (FAIRE) analysis
FAIRE analysis was performed according to Giresi et al. 2009. Briefly, 2x10 8
cells were fixed using 1 ml of 37% formaldehyde for 20 minutes at room
temperature. Cells were lysed using lysis buffer and sonicated for 4 cycles (30
seconds on/ 30 seconds off) using Bioruptor®300 (Diagenode Inc.) at high
output. Sonication sample (25µl) (to check efficiency of sonication) and input
sample (50µl) were taken out after sonication. DNA was extracted from
remaining lysate by performing phenol chloroform extraction. Input sample and
sonication sample were kept for reverse crosslinking overnight at 65ºC after
adding 125 mM NaCl and treated with RNAse A and Proteinase K before
extracting DNA. DNA from all samples was precipitated and purified using
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Qiaquick spin PCR purification kit (Qiagen). The amount of DNA extracted was
measured by quantitative PCR using iTaq SYBR Green Supermix with ROX (Biorad) in an Opticon II (Bio-rad). The amount of FAIRE-extracted DNA was
normalized to that of the input DNA.
VSG cloning
RNA was collected from 50x10 6 cells using RNAstat 60 (Tel-Test Inc). RNA
samples were treated with DNaseI (Qiagen) and purified using RNeasy column
(Qiagen). Reverse transcription was performed using polydT primers. PCR was
performed using cDNA as the template. Forward primer was designed to
recognize spliced leader sequence (present on each mature mRNA) and
backward primer was designed to recognize C-terminal region of VSG (which is
similar in all VSGs). PCR products were purified and sent for sequencing.
Sequences were compared with the T. brucei genome using BLAST to determine
the VSGs expressed in each cell line.
Statistical analysis
P-values of unpaired t-tests were calculated using the GraphPad Prism
software.
Micrococcal nuclease (MNase) digestion
5x107 cells were collected and washed with 1xTDB (BF cells) or 1x PBS (PF
cells). Cells were permeabilized using 40 mM digitonin. All samples were treated
with 1 unit of Micrococcal nuclease (Worthington Biochemicals) for 1, 2.5 or 5
minutes. EDTA and EGTA (final concentration of 10 mM each) were added to
terminate the reaction. DNA was subsequently extracted by phenol-chloroform.
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Equal amount of DNA (for untreated and treated samples) was loaded and
separated by agarose gel electrophoresis. EtBr-stained gel was scanned using
Typhoon FLA 9140 (GE healthcare life sciences). After scanning, DNA was
treated as described for southern blot analysis and blotted onto the Hybond nylon
membrane (GE healthcare life sciences). After UV cross-linking, the blot was
hybridized with the appropriate radiolabeled probe at 65ºC overnight. After
hybridization, the blot was washed three times with CHURCH wash for 15 minute
each and exposed to a phosphorimager screen (GE Healthcare Life Sciences).
Telomere southern blot analysis
Genomic DNA was isolated using the DNA spooling method (de Lange et al.
1990). An appropriate amount of genomic DNA was digested overnight at 37ºC
by using frequent cutting enzymes such as AluI and MboI. The DNA
concentration was measured. A 0.7% agarose gel with 20x20 cm dimensions
was prepared by using 0.5xTAE. 1-2 µg ( for telomere blots) or ~12 µg (for single
copy genes) of digested genomic DNA was loaded per lane along with an
appropriate DNA marker. Initially, the gel was run for 1 hour at 30 volts followed
by overnight at 50 volts. In total, the gel was run for ~1,000-1,100 V•hrs. The
EtBr-stained gel was scanned using Typhoon FLA 9140 (GE healthcare life
sciences) by placing a ruler next to it. The DNA was depurinated, denatured,
neutralized, and blotted onto a Hybond nylon membrane (GE Healthcare Life
Sciences) in 20xSSC (3 M NaCl, 0.3 M sodium citrate) overnight. The blot was
UV cross-linked (Stratalinker UV crosslinker) and hybridized with the appropriate
radiolabeled probe.
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Pulsed field gel electrophoresis
To prepare DNA plugs, ~150x10 6 cells were harvested and washed with
1xTDB (BF cells) or 1xPBS (PF cells). After centrifugation, cell pellets were
resuspended in L-buffer (0.01 M Tris-HCl pH 7.6, 0.02 M NaCl, 0.1 M EDTA pH
8.0) to obtain a final concentration of 4x10 8 cells/ml and incubated at 50ºC for 10
minutes. Equal volume of 1.6% of low melting point agarose (Agarose type VII,
Sigma Aldrich) in L-buffer (50ºC) was added to the cells. Cells were mixed and
loaded into disposable molds at a concentration of ~1x10 7 cells per plug. Plugs
were allowed to solidify at room temperature, subsequently, plugs were
incubated in L-buffer with 1% Sarkosyl and 1 mg/ml Proteinase K at 50ºC for 48
hours. After 48 hours, the plugs were washed twice with L-buffer followed by
incubation in L buffer with Proteinase K for another 48 hours at 50ºC. DNA plugs
were finally washed and stored in L-buffer at 4ºC.
A 1.2 % agarose gel was prepared using 0.5xTris-borate-EDTA (TBE). DNA
plugs were loaded on the gel with the appropriate marker (H. wingei
chromosomal DNA). Intact chromosomes were separated in a CHEF DR II (BioRad) using the following conditions: initial pulse 1,500 seconds, ending pulse 700
seconds, voltage 2.5 volts/cm, at 14ºC for 120 hours. Subsequently, the gel was
stained for 1 hour in 0.5xTBE containing 1 µg/ml of Ethidium Bromide and
destained in ddH2O for 30 minutes. The EtBr-stained gel was scanned using
Typhoon FLA 9140. DNA was depurinated, denatured, and neutralized using
southern blot analysis conditions. DNA was blotted onto the Hybond nylon
membrane in 20X SSC followed by UV cross -linking. The blot was hybridized
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with appropriate radiolabeled probe at 65ºC overnight, washed, and exposed to a
PhosphorImager screen (GE healthcare life sciences).
G-overhang analysis
Pulsed field gel electrophoresis followed by in-gel hybridization was
performed to quantify the telomere G-overhang signal. The same DNA sample
was run in duplicates and after electrophoresis the gel was dried overnight in a
gel dryer (Bio-rad). The DNA-containing gel was prehybridized at 50ºC for 30
minutes in a CHRUCH mix. TELC4 oligo ((CCCTAA)4) and TELG4 oligo
((TTAGGG)4) were end-labeled by Polynucleotide kinase with ATP (γ -32 P). One
gel was hybridized with the TELC4 oligo to detect the G-strand overhang and the
other gel with the TELG4 oligo to detect the C-stand overhang. The latter serves
as a negative control. Both gels were hybridized overnight at 50ºC in CHURCH
mix. After hybridization, gels were washed three times for 30 minutes each with
4xSSC (0.6 M NaCl and 0.06 M sodium citratre) at 50ºC followed by a final wash
in 4xSSC with 0.1%SDS for 30 minutes at 50ºC. Gels were wrapped in plastic
wrap and exposed to PhosphorImager screens. After overnight exposure, signals
were quantified using Typhoon FLA 9140. Subsequently, both gels were
denatured (1.5 M NaCl and 0.5 M NaOH) for 30 minutes and neutralized for 30
minutes (3 M NaCl and 0.5 M Tris-HCl, pH 7.0). After rinsing with ddH2 O, the
gels were prehybridized in CHURCH mix at 55ºC for 1 hour. Hybridization was
done using the same TELC4 and TELG4 probes at 55ºC for overnight. Gels were
washed the same as described above and exposed to PhosphorImager screens
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for 2 hours. Signals were quantified using Typhoon FLA 9140. This signal was
used as a loading control.
The following formula was used to calculate the telomere G-overhang signal:
G-overhang signal for any given sample = (Native TelC4 signal)/ (Denatured
TelC4 signal)
The change in the G-overhang signal was calculated by normalizing Goverhang levels at different time points (induced samples) with that at the zero
time point (uninduced samples).
In vitro transcription and translation of TbRAP1
The TbRAP1 ORF containing the Kozak sequence was cloned after the T3
promoter in the pBlueScript SK vector. pSK-TbRAP1 (Kozak) was linearized
using PvuI and purified using the Qiaquick spin PCR purification kit (Qiagen).
1µg of digested and purified plasmid was used as the template to for in vitro
transcription using the mMESSAGE mMACHINE ® T3 transcription kit (Thermo
Fisher Scientific Inc.) according to the manufacturer’s protocol. After completing
transcription, the product was treated with DNaseI and RNA was precipitated
using Lithium chloride. The resulting RNA pellet was washed once with cold 70%
ethanol and

resuspended in ddH2 O.

RNA

was

electrophoresed in a

formaldehyde gel to determine the quality and the yield of transcribed RNA.
1 µg of the transcript was used for in vitro translation using the TNT® T7/T3
Coupled Reticulocyte Lysate System (Promega) with S 35 labeled Methionine
according to the manufacturer’s protocol. Lysate containing translated TbRAP1
was separated on a 10% polyacrylamide gel, which was subsequently fixed in
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5% methanol and 7% acetic acid for 30 minutes followed by drying for 30
minutes at 80ºC using a Gel dryer (Bio-Rad). The dried gel was exposed to a
PhosphorImager screen overnight.
Electrophoretic mobility shift assay (EMSA)
The (TTAGGG)12 probe was prepared as previously discussed (Zhong et al.
1992). Purified GST-TbTRF was available in the lab (Li et al. 2005). TbRAP1 was
obtained by performing in vitro transcription and translation as described above
(lysate containing TbRAP1). Proteins were incubated with 80% glycerol, 1 µg/µl
of sheared E. coli DNA, 200 mM Glycine pH 7.6, 100 ng/µl β-casein, 10 mM
dithiothreitol, 1 ng/µl of probe, and cold competitor (non radiolabeled (TTAGGG)5
probe) for 20 minutes at room temperature. Antibody was added when necessary
and incubated for another 20 minutes at room temperature. All samples were
loaded onto a 0.6% agarose gel and separated in 0.1x Tris-borate-EDTA. Gel
was dried at 80ºC for 2 hours by placing a DE-81 membrane underneath. After
drying, the gel was exposed overnight to a PhosphorImager screen (GE
Healthcare Life Sciences).
Cloning of TbTRFH domain mutants
The N-terminal half of the TbTRFH domain upstream of the helix to be deleted
along with the N-terminal region of TbTRF was PCR-amplified using primers
containing the EcoRI and HindIII sites. The TbTRFH region downstream of the
helix to be deleted to the end of the TbTRF was PCR-amplified using primers
containing the HindIII and BamHI sites. The wild type TbTRF gene previously
cloned in the pBTM116 vector (lex A-fusion bait vector) was used as the template

49

in the PCR reactions. Hence, the two fragments flanking the helix to be deleted
were generated by PCR. After digestion and purification, the two fragments were
simultaneously ligated with the pBTM116 vector that was digested with EcoRI
and BamHI to obtain the lexA-fused TbTRF with the helix-deletion mutation. This
procedure was repeated to delete each helix in the TbTRFH domain. For helix 1
deletion, the N-terminal region upstream of helix is very short. Hence annealed
oligo pairs with appropriate restriction sites instead of the PCR product was used
for ligation.
All seven helix mutants were subsequently cloned into the pACT2 (GAD)
vector. Specifically, each mutant was PCR-amplified using primers having the
BamHI and XhoI restriction sites and cloned into pACT2 vector.
Yeast transformation
Single colony from a freshly streaked L40 cells was inoculated in YPD
medium for overnight at 30ºC with rotation. OD600 was measured to determine
the cell concentration. The overnight yeast culture was used to inoculate
appropriate amount of YPD medium (10 ml/transformation) so that the OD600 of
the new culture was ~0.1. The new yeast culture was grown till OD600 reaches
~0.5. Yeast cells were harvested by centrifugation at 6,446 g for 5 minutes and
the cell pellet was resuspended in 10 ml sterile water. Cells were centrifuged at
6,446g for 5 minutes again, and the cell pellet was resuspended in freshly
prepared lithium solution (1xTBE pH7.5/1x lithium acetate (0.1M, pH7.5)). For
each transformation 5 µg of plasmid DNA was fully mixed with 200 µl of yeast
cells and 1.2 ml of freshly prepared Polyethylene glycol solution (40% PEG,/1x
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Tris-EDTA buffer pH 7.5/1x lithium acetate). The DNA/yeast cell mixure was
rotated at 100 rpm at 30ºC for 30 minutes. Cells were heat shocked for precisely
15 minutes at 42ºC and centrifuged for 15 seconds to obtain the cell pellet. Cells
were resuspended in 200 µl of 1x Tris-EDTA buffer and plated on Tryptophan
and Leucine dropout plates. Plates were incubated at 30ºC for ~3-4 days to
obtain yeast transformants.
Yeast two-hybrid analysis
pBTM116-based LexA binding domain (LexABD)-fused protein and pACT2based Gal4 activation domain (GAD)-fused protein were co-expressed in yeast
L40 transformants. The interaction between LexABD and GAD fusion proteins
was represented as the LacZ reporter gene expression. β-galactosidase activity
was measured using ONPG (o-nitro-phenyl-β-D-galactopyranoside) as the
substrate . Single colonies of yeast transformants were inoculated in Tryptophan
and Leucine dropout medium and allowed to grow for ~18-20 hours at 30ºC with
constant rotation. OD600 was measured to determine the cell concentration of
the overnight yeast culture. Yeast cells were centrifuged and the cell pellet was
washed with 1 ml ddH2 O then resuspended in 200 µl Z buffer (60mM
Na2HPO4•7H2O, 40mM NaH2PO4.H2O, 10mM KCl and 1mM MgSO4•7H2O). 100
µl of this cell suspension was transferred to a fresh Eppendorf tube along with
two tubes containing only z buffer (for blank purpose). Cells were quickly frozen
using liquid nitrogen and subsequently thawed b y incubating at 37ºC. 900 µl of z
buffer containing β-mercaptoethanol and 200 µl of z buffer containing 4 mg/ml
ONPG was added to the cells and immediately incubated at 30ºC. 500 µl of 1 M
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Na2CO3 was added to stop the reaction after the sample turned yello w. The time
required for each sample to turn yellow was noted. At the end of experiment,
cells were pelleted and the supernatant was used to measure OD 420.
The final β-glactosidase activity was calculated using the following formula:
Unit = 1000*OD420/(OD600 * time * dilution factor/10)
Dilution factor = Volume of cells used (4 ml in this case)/volume of Z buffer used
to resuspend the cell pellet (200 µl in this case)
Northern blot analysis
A 1.5% agarose gel containing formaldehyde was prepared in MOPS buffer
(0.4 M MOPS, 0.1 M NaOAc and 0.01 M EDTA). 2-5 µg (to detect VSGs and
other transcripts) or 10 µg (to detect TERRA transcript) of RNA was mixed with
premix (1.5 µl 10xMOPS, 2.6 µl 37% formaldehyde, 7.5 µl Formamide, 3 µl 5x
loading buffer and Ethidium bromide). 5 µg of RNA marker was also mixed with
premix. Samples were mixed and incubated at 65ºC for 10 minutes. After
heating, samples were immediately loaded onto the gel. Gel was run at ~5V/cm
(50 volts in this case) using 1xMOPS buffer. The EtBr stained gel was scanned
using a Typhoon FLA 9140 on the completion of running and washed in ddH 2O
for one hour by gentle rotation. The gel was blotted onto a nylon hybond
membrane (GE healthcare life sciences) for overnight in 20x SSC (3 M NaCl, 0.3
M sodium citrate). UV crosslinking was performed and the blot was prehybridized
at 55ºC for one hour using the CHURCH mix. Hybridization was performed
overnight at 55ºC using the appropriate radiolabeled probe. The blot was washed
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three times for 15 minutes each at 55ºC using the CHURCH wash, wrapped, and
exposed overnight to a Phosphorimager screen (GE healthcare life sciences).
To detect the TERRA transcript, hybridization was performed at 55ºC
overnight and the blot was washed twice for 15 minutes each at 65ºC using
0.1xSSC (15 mM NaCl, 1.5mM sodium citrate)/0.1% SDS followed by exposure
to a phosphorimager screen overnight.
RNA Immunoprecipitation (RNA IP)
Dynabead protein G beads (Thermo Fisher Scientific Inc.) were prepared
for the immunoprecipitation. 50 µl of beads were washed and resuspended in
200 µl of antibody binding and washing buffer (1xPBS/0.02% Tween 20). An
appropriate antibody was added to the beads and the mixture was kept for
antibody coupling at 4ºC on a rotor. 2x108 cells were harvested and washed once
with 1xTDB. The cell pellet was resuspended in 1 ml NET-5 buffer (40 mM TrisHCl, pH 7.5, 420 mM NaCl, 0.5% Nonidet P-40, 2 mg/ml aprotinin A, 1 mg/ml
leupeptin, 1mg/ml pepstatin A and 10 units of RNAsin). Cells were lysed by
repeated freezing/thawing technique by freezing them in -80ºC. Repeated
freezing and thawing was done three times and lysate was cleared by
centrifugation at 1,5682 g for 10 minutes at 4ºC. The lysate was transferred to a
fresh tube.100 µl of input sample was taken out and the rest of the lysate was
equally divided between the control IP (no antibody) and the desired IP. Tubes
were rotated at 4ºC for three hours. After incubation beads were thoroughly
washed thrice using 1xPBS and samples were eluted using elution buffer (50 mM
Tris-HCl, pH8.0, 10 mM EDTA and 1% SDS). RNA was extracted from all
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samples including the input sample by phenol/chloroform. 50 µl of 5 M
ammonium acetate, 15 µl of 7.5 M lithium chloride, 1 µl of 20 mg/ml glycogen
and 850 µl of 100% ethanol was added to 300 µl of aqueous phase for
precipitating RNA. Samples were stored overnight at -20ºC. All the samples were
treated with DNaseI before performing a RNA slot blot experiment.
RNA slot blot
The slot blot manifold was treated with 0.1 M NaOH before assembly and
rinsed with distilled water. The Hybond nylon membrane was pre -treated with
10xSSC for 10 minutes before assembly into the manifold. Each slot of manifold
was filled with 10xSSC. RNA samples were treated with DNaseI at room
temperature for precisely 20 minutes. At the completion of incubation, 3 volumes
of denaturing solution (500 µl formamide, 162 µl of 37% formaldehyde, 100 µl of
MOPS buffer) was added to the RNA samples and samples were incubated at
65ºC for 15 minutes. At the end of incubation all the samples were kept on ice
and 2volumes of ice-cold 20xSSC was added. Samples were allowed to pass
through manifold. 1 ml of 10xSSC was allowed to filter through manifold after
loading the samples. The apparatus was disassembled, the blot was allowed to
dry and UV-crosslinked (Stratalinker UV cross-linker).
Blots were pre-hybridized for one hour at 55ºC using the CHURCH mix.
Hybridization was done at 55ºC overnight using an appropriate radiolabeled
probe. Blots were washed twice for 15 minutes each at 65ºC using 0.1X SSC and
0.1% SDS and exposed overnight onto a PhosphorImager screen (GE
Healthcare Life Sciences).

.

54

CHAPTER III
TbRAP1-MEDIATED VSG SILENCING IN T. BRUCEI

INTRODUCTION
RAP1 (Repressor/Activator Protein 1) is one of the intrinsic and wellcharacterized components of the telomere complex in mammalian cells, budding
yeast, fission yeast, and T. brucei (Conrad et al. 1990, Li et al. 2000, Kanoh and
Ishikawa 2001, Yang et al. 2009). It plays various roles in telomere end
protection, telomere length regulation, and telomeric silencing.
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(A)

(B)

Figure 3-1: The domain structure of RAP1 in various organisms (Kabir et al.
2010). (A) A diagram depicting the conserved protein motifs of RAP1 in
mammals and yeasts. Its TRF2 like interacting partners are depicted as well. The
empty cyan box in S. pombe indicates that it has a sequence similarity with S.
cerevisiae myb-fold; however, the structure has not yet been determined. It is not
known whether S. pombe RAP1 contains RCT domain. (B) Conserved motifs of
TbRAP1 along with its protein interacting partner TbTRF.
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ScRAP1 directly binds to the telomeric DNA through its myb and myb-like
domains (Konig et al. 1996), while hRAP1 and SpRAP1 do not seem to directly
bind to the telomeric DNA in vivo. Instead, they depend on TRF2 and TAZ1 for
their recruitment to telomeres, respectively (Li et al. 2000, Kanoh and Ishikawa
2001). Recently, an in vitro study using EM analysis showed that hRAP1 could
bind to the telomeric DNA sequence (Arat and Griffith 2012). However, the proof
of DNA binding in vivo is still lacking. The TbRAP1 domain structure is very
similar to that of ScRAP1 and hRAP1. However, it is still not clear whether
TbRAP1 can interact with telomeric DNA by itself or solely depends on TbTRF
for its recruitment. The RCT (RAP1 C-terminus) domain present in RAP1 is
thought to be required for protein-protein interaction (Kabir et al. 2010), while the
functions of the RAP1 BRCT domain are unknown.
Genes present on the subtelomeric region are often silenced due to the
heterochromatic nature of telomeres. This phenomenon is known as telomere
position effect (TPE) or telomeric silencing. So far, TPE has been identified in
Drosophila melanogaster, yeast, human, mouse, T. brucei, and Plasmodium
falciparum (Hazelrigg et al. 1984, Gottschling et al. 1990, Horn and Cross 1995,
Baur et al. 2001, Frietas-Junior et al. 2005, Duraisingh et al. 2005, Pedram et al.
2006). RAP1 is known to play an important role in TPE and in expression of
subtelomerically located genes.
In S. pombe, the deletion of SpRAP1 led to a loss of telomere silencing as
well as a loss in telomere clustering towards spindle pole body, and increased
telomere length (Kanoh and Ishikawa 2001). In human cells a telomere position
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effect has been identified. However, the proteins involved in TPE are currently
unknown (Baur et al. 2001).
ScRAP1 plays an important role in TPE. It recruits Sir3/Sir4 to the telomere to
regulate telomeric silencing and heterochromatin formation/maintenance (Moretti
et al. 1994, Cockell et al. 1995), and the mechanism is well characterized. Sir3
and Sir4 together recruit Sir2, an NAD +-dependent histone deacetylase that can
remove the acetyl group from histone H3 at K9 and K14 residues, and from
histone H4 at K16 (Moazed et al. 1997, Bourn et al. 1998, Imai et al. 2000,
Moretti et al. 2001). Sir3 in turn recognizes the unacetylated H4K16 (Hect et al.
1995). Therefore, binding of Sir3 and Sir4 recruits Sir2, which deacetylates
neighboring histone tails and allows the subsequent binding of Sir3 and Sir4 to
neighboring nucleosomes, allowing the propagation of the heterochromatin
structure from telomere to subtelomeric region (Rusche et al. 2002). The loss of
the RCT domain of ScRAP1 leads to de-repression of subtelomeric genes,
indicating that ScRAP1 is required for proper telomeric silencing (Kyrion et al.
1993). In T. brucei, homologs of Sir3 and Sir4 are not known. However,
homologs of Sir2 have been identified (Garcia-salcedo et al. 2003). TbSir2rp1
(the only homolog located in the nucleus) is required for silencing a reporter gene
targeted to a subtelomeric locus but not VSG (Alsford et al. 2007).
The proper regulation of VSG silencing is of the utmost importance for
parasite survival and pathogenesis. TbRAP1 (Tb11.03.0760) was identified as a
TbTRF-interacting protein in a yeast 2-hybrid screen using TbTRF as bait (Yang
et al. 2009). TbRAP1 is an essential protein. It was confirmed using ChIP, CO-
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ImmunoPrecipitation (CO-IP), and Immunofluorescence (IF) that TbRAP1
localizes to the telomere. Most importantly, TbRAP1 is required for VSG silencing
in BF form T. brucei (Yang et al. 2009). Upon depletion of TbRAP1, multiple
VSGs were expressed as confirmed by qRT-PCR and western blot analysis. IF
confirmed that more than one silent VSGs were expressed on the surface of
TbRAP1-depleted T. brucei cells. However, the observed VSG de-repression
was not at the same level as the fully activated VSG, suggesting that TbRAP1
independent mechanisms are also involved in ES expression regulation.
Telomere proximal genes were more strongly de-repressed compared to
telomere distal genes upon depletion of TbRAP1. Thus, finding confirmed that in
T. brucei TbRAP1 plays an important role in VSG silencing. However, the
mechanism of TbRAP1-mediated silencing is not fully understood.
In PF cells, T. brucei growing in the mid-gut of tsetse fly, all VSGs are silent,
and a different surface protein called procyclin is expressed. Metacyclic VSGs
(mVSGs) expressed during the metacyclic stage (in the salivary glands of fly) are
silent in both BF and PF cells. We hypothesized that TbRAP1 may also be
required in silencing ES-linked VSGs in PF cells as well as mVSGs in both BF
and PF cells.

RESULTS
TbRAP1 is essential for PF T. brucei survival
In order to study the role of TbRAP1 in PF cells, various independent clones
carrying inducible TbRAP1 RNAi vector were established. The TbRAP1 RNAi
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vector was inserted in the rDNA spacer of 29-13 cells. 29-13 (PF) cells express
the tet repressor and the T7 polymerase, which allow inducible expression of a
double stranded TbRAP1 RNAi fragment (Wirtz et al. 1999). The RNAi construct
contains the TbRAP1 sequence encoding its C-terminal domain. RNAi is induced
upon adding doxycycline. We obtained a pool (PRi-Pool) of transfected cells as
well as various independent clones (PRi-B2, PRi-C1 and PRi-C2) by limiting
dilution. Upon adding doxycycline (2µg/ml), depletion of TbRAP1 was achieved
and growth arrest was observed (Figure 3 -2).
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Figure 3-2: Depletion of TbRAP1 in the PF cells. (A) Growth curve analysis for
the PRi-pool and control cells carrying empty vector under induced (+Dox) or
uninduced (-Dox) conditions. Y-axis depicts population doubling calculated as
average from six independent experiments. Error bars represent standard
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deviation. (B) Western blot analysis to detect knockdown of TbRAP1 in PRi-pool
and empty vector cells. Whole cell lysate was collected before (Day 0) and after
induction (Day 2 & 3) to detect TbRAP1 and TbTRF using antibodies against
endogenous proteins. Tubulin was used as a loading control. (C), (D) and (E)
Growth curves of independent TbRAP1 RNAi clones (PRi-C1, PRi-C2, and PRiB2, respectively). Population doubling was calculated as an average from three
independent experiments. Error bars represent standard deviation. (F) Whole cell
lysate was collected before and after induction of clone PRi-C2 to detect
TbRAP1. EF-2 (elongation factor 2) was used as a loading control. (G)
Complementation of TbRAP1 by ectopically expressing F2H-TbRAP1 in PRi-pool
cells. Western blot analysis depicts ectopically tagged TbRAP1 (running slightly
higher at day 2 & 3) as well as endogenous TbRAP1 before and after induction.
(H) Growth curve of PRi-pool/F2H-TbRAP1 cells after adding doxycycline. The
population doubling was plotted for a single growth analysis.

Upon depletion of TbRAP1, we observed a severe growth defect by day 2 in
PRi-Pool cells (figure 3-2 A). Control cells carrying empty vector did not have any
growth defects. Western analysis confirmed that the TbRAP1 protein was
significantly depleted by day 2 of induction. Depletion of TbRAP1 did not have
any effect on protein levels of another telomeric protein, TbTRF (figure 3-2 B).
TbRAP1 and TbTRF protein levels were unaffected in co ntrol cells upon
induction with the same amount of doxycycline. We obtained several
independent clones that had various degrees of growth defects after depletion of
TbRAP1. PRi-C2 had the strongest growth arrest (figure 3-2 D). Western
analysis of cell lysate collected from PRi-C2 showed that a significant amount of
TbRAP1 was depleted within 24 hours of induction (figure 3-2 F). In order to
avoid phenotypic variations associated with the clonal cell lines, we decided to
use PRi-Pool cells for further studies and key phenotypes were also verified in
PRi-C2 clone. Complementation of TbRAP1 knockdown was achieved by
expressing an ectopic F2H (Flag-HA-HA) tagged allele of TbRAP1. Expression of
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both vectors (ectopic F2H-TbRAP1 and TbRAP1 RNAi) was under the control of
tet operator and is induced simultaneously upon adding doxycycline. After
multiple independent transfections and screening several clones, we were able to
achieve partial complementation as seen in western analysis (Figure 3-2 G) and
growth analysis (Figure 3-2 H). Ectopically tagged TbRAP1 was expressed upon
induction (as seen by slightly higher mobility running band), however by day 3
the protein levels were a little lower than at day 2. Similarly, normal growth was
restored at day 2 but was a little delayed by day 3. This finding suggests that the
complementation was partial and that by day 3 the RNAi was able to deplete
even ectopically expressed TbRAP1, possibly due to a stronger expression of the
TbRAP1 double stranded RNA than the ectopic wild-type TbRAP1 allele.
Next, flow cytometry analysis was performed to examine the cell cycle profile
of PRi-pool cells after depletion of TbRAP1. Cells were collected before and after
depletion of TbRAP1 and subjected to propidium iodide staining to meas ure the
DNA content. We observed a mild increase in G2/M and sub G1 population with
a decrease in G1 population upon depletion of TbRAP1 (figure 3-3 C). These
results are very similar to those observed previously in BF cells upon TbRAP1
depletion (Yang et al. 2009).
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Figure 3-3: Flow cytometry analysis of PRi-pool cells. (A) Results from two
independent analyses are shown. Cells were collected before (Day 0) and after
(Day1, Day2 and Day3) depletion of TbRAP1. (B) Gating schematics of
uninduced PRi-Pool cells in flow cytometry analysis. Sub-G1 population contains
DNA content less than 2C and represents cells experiencing DNA degradation.
PI, propidium iodide intensity. (C) Quantification of cell population at various cell
cycle stages of PRi-pool cells before (Day 0) and after (Day 1, 2 & 3) depletion of
TbRAP1. P values were calculated to compare day 1, 2, and 3 with day 0 using
unpaired t-test. *, 0.01<P≤ 0.05; **, 0.001<P≤ 0.01.
TbRAP1 is required for silencing ES-linked VSGs in PF cells.
We wanted to test whether TbRAP1 plays similar roles in regulating VSG
silencing in PF cells as it does in BF cells. Total RNA was collected before and
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after depletion of TbRAP1 to compare steady state mRNA levels of various ESlinked VSG.
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Figure 3-4: ES-linked VSGs are de-repressed in PF cells upon depletion of
TbRAP1. qRT-PCR analysis was performed to measure steady state mRNA
levels of ES-linked VSGs and control genes before (day 0) and after depletion
(day 2 & 3) of TbRAP1 in PRi-pool cells (A) and control cells (B). Day 0 value
was set to 1 but not shown. Fold change in mRNA level was calculated for day 2
& 3 (after depletion) by normalizing against day 0 (before depletion). All samples
were normalized with tubulin as an internal loading control. Fold changes in
mRNA levels are shown for three independent experiments. (C) Western
analysis to determine levels of various proteins in PRi-pool cells (left) and
PF/TbTRF RNAi cells (right). Whole cell lysate was collected before (day 0) and
after (day 1, 2, & 3) adding doxycycline. (D) qRT-PCR analysis to measure
steady state mRNA levels of ES-linked VSGs and control gene in PRi-C2 cells.
Day 0 value was set to 1 but is not shown. Fold change was calculated by
normalizing after TbRAP1 depletion value by before TbRAP1 depletion.
Steady-state mRNA levels were estimated for several ES-linked VSGs and
control genes before and after depletion of TbRAP1 in PRi-Pool cells by qRTPCR analysis. 35% of TbRAP1 protein was left by day 1 after induction of RNAi
vector, however, by day 2 only 10% of protein was left. Hence we decided to
collect RNA samples at day 2 and 3 following induction. Upon depletion of
TbRAP1 in PRi-pool cells, mRNA levels of all tested VSGs (VSG 2, 3, 6, 11, and
16) increased by several ten- to several hundred-fold (figure 3-4 A). No
significant changes in mRNA levels were observed in control cells (figure 3-4 B).
We also tested the expression of RNA Pol II-transcribed TbPGI (a glycolytic
protein), TbRPS15 (a ribosomal protein), and the RNA Pol I-transcribed rRNA.
Expression of these genes was unaffected upon depletion of TbRAP1,
suggesting that TbRAP1’s effect on VSGs is specific. Western analysis
confirmed depletion of TbRAP1 and expression of VSG2 protein by day 2
following induction (figure 3-4 C). Levels of TbTRF (TbRAP1-interacting partner
and another telomeric protein) remained unchanged upon depletion of TbRAP1.
Induction of TbTRF RNAi in PF cells leads to growth arrest by day 2 (Li et al.

66

2005). We did not detect any VSG2 expression upon depletion of TbTRF (figure
3-4 C right), suggesting that VSG derepression is not a consequence of cell
growth arrest and that TbRAP1 is required for VSG silencing in PF T. brucei
cells. We also tested steady state mRNA levels of two representative VSGs in
the PRi-C2 clone to further confirm this phenotype. Several hundred-fold of
derepression was observed for both tested VSGs while rRNA expression was
unaffected (figure 3-4 D). In addition to ES-linked VSGs, VSGs are also present
on subtelomeric regions of minichromosomes. Minichromosomes mostly contain
177 bp repeats and terminal telomere repeats. The VSGs located on
minichromosomes lack upstream promoters.
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Figure 3-5: Detection of VSG671 on minichromosomes. Southern blot analysis
was performed to test the presence of VSG671 on minichromosomes in BF (RiCT and Ri-BRCT) and PF (PRi-pool) RAP1 RNAi cells. Pulsed field gel
electrophoresis was performed followed by hybridization with VSG671 probe
(right panel). The EtBr stained-gel is depicted on the left. Arrow indicates
minichromosome species.
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DNA plugs were made from BF and PF TbRAP1 RNAi cells. Pulsed field gel
electrophoresis was performed using these plugs under conditions that separate
intact T. brucei chromosomes (Li et al. 2005). VSG671 was detected on
minichromosomes in all three TbRAP1 RNAi cell lines (figure 3-5). We
subsequently tested whether VSG671 is derepressed upon depletion of TbRAP1
in PRi-pool cells. No VSG671 mRNA was detected in the northern blot analysis
(data not shown) after knockdown of TbRAP1, suggesting that derepression of
VSG requires functional upstream promoter.
TbRAP1 is required for silencing mVSGs in PF cells.
Metacyclic VSGs (mVSGs) are major surface proteins expressed in the
metacyclic form of T. brucei in salivary glands of the tsetse fly. The mVSGs are
expressed from subtelomerically located monocistronic expression sites. The
mVSGs are silent in both PF and BF forms. However, their silencing mechanisms
are not understood. Five mVSG genes (mVSG 397, 531, 639, 653, and 1954)
were identified in our lab strain (Kolev et al. 2012). We wanted to determine
whether TbRAP1 plays a role in silencing mVSGs in PF and BF T. brucei cells.
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Figure 3-6: Silencing of mVSGs in PF cells. (A) Steady state levels of mVSG
mRNA was measured before (day 0) and after (day 2, 3) depletion of TbRAP1 in
PRi-pool (A) and control cells (B) using qRT-PCR analysis. Fold change is
calculated for day 2 & 3 compared to that of day 0 value, which is set to 1 but not
shown. Values for three independent induction experiments are shown.
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Upon depletion of TbRAP1 in PF cells, steady state levels of all tested
mVSGs increased from several to several 10-fold. In control, no change in
steady-state mRNA levels of mVSGs was detected. These results indicated that
TbRAP1 not only plays a role in silencing ES-linked VSGs but also is required for
silencing mVSGs in PF cells.
TbRAP1 is required for silencing mVSGs in BF cells.
We wanted to test whether TbRAP1 is also required for silencing mVSGs in
BF T. brucei cells. Two BF TbRAP1 RNAi cell lines were generated. One cell line
had expressed the pZJMβ-based RNAi construct (Wang et al. 2000) containing
the BRCT domain of TbRAP1 (Ri-BRCT) while the other the RCT domain (Ri-CT)
inserted into the rDNA spacer region. Since these cell lines were not previously
characterized, we decided to confirm critical phenotypes of TbRAP1 depletion in
these cell lines first.
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Figure 3-7: Depletion of TbRAP1 in the BF cells. (A) A representative growth
curve of the two TbRAP1 RNAi strains (Ri-CT & Ri-BRCT). The population
doubling was calculated in the presence (+) or absence (-) of doxycycline (Dox).
(B) & (C) qRT-PCR analysis to determine steady state levels of ES-linked VSGs
in Ri-CT & Ri-BRCT cell lines respectively. Values were calculated before (0 hr)
and after (24 hr) depletion of TbRAP1. Fold change in mRNA levels was
calculated compared to day 0. Results for 5 (Ri-CT) and 3 (Ri-BRCT)
independent experiments are shown. (D) Flow cytometry analysis for the Ri -CT
cell line. Results from two independent analyses are shown. Cells were analyzed
before (0 hr) and after (18, 24, & 36 hr) depletion of TbRAP1. (E) Gating
schematics of uninduced BF cells. The Sub-G1 population refers to cells having
DNA content less than 2C, which often experienced DNA degradation. (F)
Quantification of the cell population at various cell cycle stages of the Ri-CT cells
before (0 hr) and after (18, 24, & 36 hr) depletion of TbRAP1. P values were
calculated to compare 18, 24 & 36 hr values with 0 hr value using unpaired t-test.
*, 0.01<P≤ 0.05; **, 0.001<P≤ 0.01.
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Upon depletion of TbRAP1 growth arrest was observed in both strains by 30
hours (figure 3-7 A). Steady state mRNA levels of various ES-linked VSGs were
tested before and after induction. As previously published (Yang et al. 2009), an
increase in VSG mRNA levels from several ten- to several hundred-fold was
observed after depleting TbRAP1 from both strains (figure 3-7 B & C). FACS
analysis showed a slight decrease in the proliferation of cells in G1 phase and,
an increase in G2/M and sub G1 phase.
After it was proved that these newly established TbRAP1 RNAi strains give
similar phenotypes as previously published, we decided to use them for further
experimentation. The role of TbRAP1 in silencing mVSGs in BF cells was tested
by collecting total RNA before (0 hr) and after (24 hr and 36 hr) depletion of
TbRAP1. By 24 hr only 6% TbRAP1 was left in the Ri-CT cells while 26% was
left in the Ri-BRCT cells. The RNA collected was then subjected to reverse
transcription and steady state mRNA levels of various mVSGs were determined
using specific primers in qRT-PCR analysis. Derepression of mVSGs was
observed from several to over 1000-fold upon depletion of TbRAP1 (figure 3-8 A
& B). No change in mVSG mRNA levels was observed in control cells (figure 3-8
C). Expression of control genes such as rRNA and TbPGI remain unaffected
upon depletion of TbRAP1. Thus, these results proved that TbRAP1 is required
for ES-linked as well as metacyclic VSG silencing in BF cells.
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Figure 3-8: Silencing of mVSGs in BF cells. qRT-PCR analysis to measure
steady state mRNA levels of mVSGs in (A) Ri-CT, (B) Ri-BRCT & (C) control
cells before (0 hr) and after (24 hr and 36 hr) depletion of TbRAP1. Fold change
in mRNA level was calculated after depletion compared to that of 0 hr whose
value is set to 1 and not shown. Values for three independent experiments are
shown.
Comparison of TbRAP1-mediated ES-linked VSG silencing at different life
cycle stages
Our results suggest that TbRAP1 is required for silencing ES-linked VSGs in
both PF and BF cells. However, it seems that derepression of ES-linked VSGs in
PF is much stronger than that in BF. From our previous studies in BF cells (Yang
et al. 2009), we know that VSG 3, 6, and 11 were derepressed up to 8 -, 23- and
41-fold respectively upon depletion of TbRAP1. Whereas in PF cells, upon
depletion of TbRAP1, the same VSGs were de-repressed up to 270-, 220-, and
260- fold respectively (figure 3-4 A).
In order to better quantify these differences, we decided to perform a
comprehensive qRT-PCR analysis. We wanted to test and compare individual
ES-linked VSG mRNA level under different conditions: i) at the silent state in
WT/PF and WT/BF cells, ii) at the derepressed state in PF and BF TbRAP1 RNAi
cells, and at iii) the fully acti ve state in BF cells. Total RNA was collected and
subjected to reverse transcription followed by qRT-PCR analysis. VSG 2, 3, and
9 were tested owing to availability of all the necessary cell lines in our laboratory.
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Figure 3-9: Strength of TbRAP1 mediated VSG silencing at PF and BF stages.
(A) Schematic representation of the status of ES-linked VSGs in various
scenarios. (B) Quantification of qRT-PCR analysis for relative mRNA levels of the
same VSG in various backgrounds. All the values were normalized to that of the
PF WT silent state, whose value was arbitrarily set to 1. The average value was
calculated from five independent experiments. Error bars represent standard
deviation. VSG derepression was analyzed at day 0 & day 2.5 in PRi-pool cells.
Derepression of VSG 3 and 9 in BF cells were analyzed at 0 hr & 36 hr in cells
originally expressing VSG2 (Ri-2 cells). While derepression of VSG2 was
analyzed at the same time points in cells originally expressing VSG9 (Ri-9 cells).
For fully active state, three BF WT cells were used: i) VSG2 expresser (SM cells)
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(Wirtz et al. 1999), ii) VSG9 expresser (PVS3-2/OD1-1 cells) (Yang et al. 2009)
and iii) VSG3 expresser (SM-derived cell lines).
Several conclusions were obtained from qRT-PCR analysis. 1) Steady state
mRNA levels of VSG were 28-, 16- and 9-fold higher in the WT BF cells
compared to the WT PF cells (figure 3-9 B PF/WT and BF/WT silent)
respectively. It is known that VSG mRNAs are less stable i n PF cells than in BF
cells where they are prevented from degradation (Berberof et al. 1995). Hence,
this could contribute to our observation. 2) TbRAP1 is required for ES-linked
VSG silencing in both the PF and BF cells since VSG derepression was
observed upon its depletion. 3) This derepression observed due to depletion of
TbRAP1 is significantly stronger in PF than in BF cells. VSG mRNA levels were
elevated on an average 333-, 527-, and 217-fold, respectively, in PF. In BF cells,
proven derepression was on an average 22-, 133-, and 30-fold, respectively
(figure 3-9 B, PF/TbRAP1 RNAi -/+Dox, BF/TbRAP1 RNAi -/+Dox). P values
were all <0.02 when comparing derepression of VSG 2, 3, and 9 in BF to that in
PF cells. Thus TbRAP1-mediated VSG silencing is stronger in PF cells than that
in BF cells. We observed that VSG mRNA level is ~3 fold lower for the uninduced
PRi-pool cells (PF/TbRAP1 RNAi –Dox) compared to PF WT cells, while
theoretically it should be the same. This observation could be due to variations
between different cell populations.
In yeast, longer telomere results in stronger telomeric silencing (Kyrion et al.
1993). It is possible that different strength of TbRAP1-mediated VSG silencing in
the PF and BF could be due to different telomere length. However, the PF and
BF strains used in this study have similar length of telomeres (on average ~15
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kb) suggesting that telomere length is not the contributing factor. Another
possibility is that TbRAP1 might not be equally depleted in PF and BF cells,
resulting in different levels of VSG derepression in both forms. To rule out this
possibility, we tested and compared TbRAP1 protein levels within all the TbRAP1
RNAi cell lines used for this study.

79

Figure 3-10: Depletion of TbRAP1 in PF and BF cells. (A-C) Representative
western blot analysis to determine depletion of TbRAP1. Whole cell lysate was
collected before (0 hr) and after depletion of TbRAP1 in Ri-2 (A), Ri-9 (B), Ri-CT,
Ri-BRCT and PRi-pool cells (C). Tubulin and EF-2 were used as loading control.
Numbers below blots indicate the average relative amount of TbRAP1 protein
levels. These numbers were calculated from 2 (Ri-2 and Ri-9) or 3 (Ri-CT, RiBRCT, and PRi-pool) independent experiments. (D) Northern analysis to
determine the relative mRNA levels of TbRAP1 in BF and PF cells. rRNA is
shown as loading control. Numbers indicate relative ratio of TbRAP1 mRNA
level. (E) Western blot analysis to determine relative protein levels of TbRAP1 in
the BF and PF cells. Tubulin was used as a loading control.
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RNA samples were collected at 36 hr (for Ri-2 and Ri-9 cells), and at 60 hr
(for PRi-pool cells). From figure 3-10 A-C, it is evident that comparative residual
amount of TbRAP1 was left in all the cell lines at respective time points. On an
average, 4% TbRAP1 was left in Ri-2 cells, 14-11% in Ri-9 cells, and 16% was
left in PRi-pool cells. Thus, it is unlikely that differential derepression of ES-linked
VSGs in PF and BF cells is due to different levels of TbRAP1 depletion. We
further confirmed that TbRAP1 mRNA and protein levels are equal in both life
cycle stages (figure 3-10 D and E). Collectively, these results suggest that,
indeed, TbRAP1-mediated silencing is stronger in PF compared to that in BF.
Such differential strength of silencing was not observed for mVSGs between both
forms.
TbRAP1 depletion led to more open chromatin structure in PF cells.
Next, we wanted to test whether TbRAP1-mediated VSG silencing involves
chromatin remodeling. In order to test this, FAIRE (formaldehyde assisted
isolation of regulatory elements) was performed (Giresi et al. 2009). In FAIRE,
cells are cross-linked, lysed, and sonicated followed by the phenol-chloroform
extraction. Protein-free DNA fragments are enriched in the aqueous phase, while
protein-bound DNA is retained at interphase. DNA from aqueous phase is
subsequently isolated. PCR analysis can then be done to estimate enrichment of
protein-free DNA fragments of interest. We were interested in testing whether
chromatin of subtelomeric ES-linked VSGs is more opened up (hence devoid of
bound protein) upon depletion of TbRAP1. FAIRE was performed to isolate
protein-free DNA before and after depletion of TbRAP1. Quantitative PCR using
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primers specific for various VSGs was performed to calculate the amount
extracted. Fold change was calculated by dividing values obtained post -TbRAP1
depletion by those obtained before depletion.

Figure 3-11: Depletion of TbRAP1 led to a more loosened chromatin structure in
the PF cells. FAIRE was performed before (day 0) and after (day 2.5) depletion
of TbRAP1 in (A) PRi-pool cells and (B) control cells. Quantitative PCR was done
using primers specific to the indicated gene loci. Fold change was calculated
from at least three independent experiments. Error bars represent standard
deviation. In PRi-pool cells, P-values were calculated by comparing ES-linked
VSG changes with the change of chromosome internal genes. Significant
differences (P<0.05) are indicated with asterisks. P-values were also calculated
for each gene between PRi-pool cells and the control cells shown by asterisks
between corresponding columns from two histograms. Control genes are
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indicated with the last four digits of their ID. Tb927.2.2430, Tb927.2.2440,
Tb09.211.1510. *, 0.01<P≤ 0.05; **, 0.001<P≤ 0.01, ***, P≤ 0.001

FAIRE was performed in TbRAP1 depleted PRi-pool cells. Upon depletion of
TbRAP1 8- to 19-fold increase in the enrichment of ES-linked VSGs was
observed compared to that in the control cells. An increase in the enrichment of
mVSG DNA of 4- to 7-fold was also observed. These differences were
significantly higher compared to that in control cells. In order to determine that
this effect of TbRAP1 depletion is telomere specific, we also tested enrichment of
DNA at several random chromosome -internal genes. A 3- to 4-fold increase in
FAIRE-extracted DNA was observed at these loci, which are modest yet
significantly higher than that in control cells. However, the enrichment at ES linked loci (8- to 9-fold) was significantly higher compared to the chromosomal
internal loci (3- to 4-fold), suggesting that TbRAP1 has a more prominent effect
on chromatin structure at subtelomeric loci. The BES promoter lies 40-60 kb
upstream of the telomeres. TbRAP1 depletion led to ~3-fold enrichment in FAIRE
extracted DNA, which is similar to that of the chromosome internal loci.
It is possible that this change in chromatin structure could be due to an
elevated transcription, rather than directly due to the loss of TbRAP1. In order to
test this possibility, the chromatin structure change o f VSG671 locus was
examined before and after depletion of TbRAP1. VSG671 is located on a
minichromosome and lacks an upstream promoter. Hence, it is not derepressed
upon TbRAP1 knockdown. An approximately 5-fold increase in FAIRE-extracted
DNA was observed for VSG671, which is significantly higher compared to that in
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control cells as well as chromosome internal loci, suggesting that the change in
chromatin compaction upon TbRAP1 depletion is not due to elevated
transcription.
Subsequently, FAIRE analysis was also performed in BF cells to test whether
TbRAP1 has a similar effect on chromatin structure as that observed in the PF
cells.
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Figure 3-12: FAIRE analysis in BF cells. FAIRE was performed before (0 hr) and
after (24 hr in Ri-CT, Ri-BRCT and control cells; 36 hr in Ri-2 and Ri-9 cells)
depletion of TbRAP1. Quantitative PCR was done using primers specific to
indicated gene loci. Fold change was calculated from at least three independent
experiments. Error bars represent standard deviation. Control genes used are
Tb11.0330, Tb927.2.2430, Tb927.2.2440, and Tb09.211.1510.
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FAIRE was performed in four independent TbRAP1 RNAi cell lines (Ri-CT, RiBRCT, Ri-2 and Ri-9) as well as empty vector control cells. Fold change in
FAIRE-extracted DNA was calculated

for ES-linked VSGs, mVSGS, a

minichromosome VSG (VSG671), ES promoter region and control genes. A
moderate increase of 2- to 3-fold was observed for ES-linked VSGs, mVSGs,
and a minichromosome VSG, which was not significantly different from that
observed in the control cells. Also, a very small change of 1- to 3-fold was
observed for the ES promoter and chromosome internal loci, which was similar to
that observed in the control cells. P-values were calculated to compare ES-linked
VSGs with chromosome internal loci within TbRAP1 RNAi cells and to compare
all loci between TbRAP1 RNAi and control cells. All calculated P-values were
>0.05, indicating that the changes in chromatin structure observed in BF cells are
not significant. Thus, unlike PF cells, TbRAP1 depletion in BF cells does not lead
to significant changes in chromatin structure.
This difference in observed phenotype was not due to different degrees of
TbRAP1 depletion. This observation was confirmed by performing western blot
analysis. At the time points when FAIRE was performed, protein levels of
TbRAP1 were around 4% for Ri-2 (figure 3-10 A), 10% for Ri-9 (figure 3-10 B),
6% for Ri-CT, 26% for Ri-BRCT, and 16% for the PRi-pool cells of wild-type level
(figure 3-10 C). This finding indicates that TbRAP1 was depleted in PF and BF
cells at similar levels.
In order to confirm that TbRAP1 depletion has different effects on chromatin
structure in PF and BF cells, we performed a Micrococcal nuclease (MNase)

86

digestion assay. Ranjodh Sandhu, another graduate student from our lab, did this
part of work. MNase digestion was performed to test accessibility of chromatin
before and after depletion of TbRAP1. TbRAP1 RNAi cells in the PF and BF
cells, as well as the control cells were treated with a fixed amount of Mnase for
increasing length of time before and after depletion of TbRAP1. Genomic DNA
was then isolated and separated on an agarose gel. We subsequently performed
Southern blot analysis by blotting DNA samples on nylon membranes followed by
hybridization with probes specific to different loci.
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Figure 3-13: A micrococcal nuclease digestion to determine the chromatin
structure changes. MNase assay was performed before and after depletion of
TbRAP1 in (A) PRi-pool cells (day 0 and day 2.5) (B) PF/Vector cells (day 0 and
day 2.5) (C) Ri-BRCT (0 hr and 24 hr) (D) BF/Vector cells (0 hr and 24 hr). In
each panel, the left panel shows an Ethidium Bromide-stained gel while the right
panel shows the hybridization result with VSG18 specific probe. Solid black dots
and arrowheads represent the limiting mobility of genomic DNA in the agarose
gel and Southern results, respectively. Asterisks indicate mono -, di-, tri-, and
tetra-nucleosomes.

PRi-pool cells were treated with a fixed amount of MNase for increasing
length of time. After 2.5-5 min, a portion of chromatin was digested into mono-,
di-, tri- and tetra-nucleosomes. However, when TbRAP1 was depleted, this
digestion was much more rapid and by 5 minutes most of the chromatin was
found in the mono-nucleosomal fraction (figure 3-13 A, compare lane 4 with lane
8 on the left). Control cells did not show any change in chromatin digestion upon
adding doxycycline (figure 3-13 B, compare lane 5 with lane 10 on the left). This
suggests that after depletion of TbRAP1, the chromatin is more opened up and
accessible to MNase digestion. Changes observed in chromatin digestion in the
Ethidium Bromide- (EtBr)-stained gel suggested that TbRAP1 depletion had a
mild global effect. In order to test effects of TbRAP1 knockdown on a specific
locus, the MNase digested DNA was blotted from the agarose gel onto a nylon
membrane and hybridized with the VSG18 specific probe. In PRi-pool cells after
TbRAP1 depletion, the entire VSG18 signal was lost by 2.5 minutes of digestion
compared to before depletion (figure 3 -13 A, compare lane 3 with lane 7 in right
panel). The VSG18-specific signal remained unaffected upon adding doxycycline
in control cells (figure 3-13 B, compare lane 5 with lane 10 in right panel). Thus it
was proven that TbRAP1 regulates VSG silencing in PF cells via chromatin
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remodeling. We further performed a MNase assay for other ES-linked VSGs,
mVSGs, and telomere DNA (Pandya et al. 2013). All of them gave similar results.
TbRAP1 depletion had a very mild effect on chromatin change at the ES
promoter region. This was similar to the result of FAIRE analysis. The change in
chromatin structure was also confirmed in PRi-C2 (independent PF/TbRAP1
RNAi clone).
Interestingly, TbRAP1 depletion had no affect on chromatin structure in BF
when analyzed by MNase digestion. No change in the chromatin digestion was
observed in EtBr-stained gels, before or after depletion of TbRAP1 in Ri-BRCT
cells (figure 3-13 C, compare lane 4 with lane 7 in the left panel). The digestion
pattern was almost the same as that observed in control cells (figure 3-13 D,
compare lane 4 with lane 8 in the left panel). We also tested the effect of
TbRAP1 depletion at the VSG18 locus. No visible difference in the digestion
pattern was seen between uninduced and induced cells (figure 3 -13 C, compare
lane 4 with lane 7 in the right panel, figure 3-13 D, compare lane 4 with lane 8 in
the right panel). This phenotype was further confirmed for other ES-linked VSGs,
mVSGs, and telomere repeats. No significant change in chromatin structure was
detected, suggesting that TbRAP1 does not affect chromatin structure
significantly in BF cells.

TbRAP1 preferentially localizes to silent ES-marked telomeres (preliminary
studies)

We wanted to test whether TbRAP1 carries out silencing of VSGs in a cisacting manner. Our previous observations indicated that the TbRAP1-mediated
90

silencing effect is position-dependent, i.e. it is stronger at telomere-proximal loci
than at telomere-distal loci (Yang et al. 2009). We wanted to test whether
TbRAP1-mediated silencing depends on the amount of TbRAP1 protein
associated with the local chromatin. If this is true, we expect that more TbRAP1
protein is associated with the silent ES than the active ES-marked telomere in
wild-type BF cells.
To

test

this

hypothesis,

we

performed

a

TbRAP1

chromatin

immunoprecipitation (ChIP) experiment. The amount of the active ES-linked VSG
DNA and a silent ES-linked VSG DNA co-immunoprecipitated with TbRAP1 was
estimated by quantitative PCR. The experiment was performed in two different
ways. First, the same VSG was examined in different BF cell lines, where the
VSG is either fully active or silent. Second, the active VSG and silent VSGs
within the same cell line were examined to determine whether different amount
TbRAP1 binds to them. Immunoprecipitation was performed using an antibody
against the endogenous TbRAP1.
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Figure 3-14: TbRAP1 preferentially binds to the silent ES-marked telomere. (A)
ChIP was performed in different BF cells lines where either VSG9 is active
(PVS3-2/OD1-1) or silent (SM and SM-derived cell line). Similar analysis was
also done in BF cell lines where a different VSG, VSG2, is either active (SM) or
silent (PVS3-2/OD1-1). After ChIP, quantitative PCR was performed using
primers specific to VSG9 and VSG2 and the enrichment of the ES-linked VSG
DNA was calculated as percent of input. Protein G beads with pre-immune serum
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were used as a negative control. Three VSG9 and two VSG2 independent
experiments are shown. As a control, enrichment of TbRAP1 at three
chromosome internally located gene was also estimaed in the same way. For
control genes, average values were calculated from four independent
experiments, and error bars represent standard deviation. Control genes are
listed using the last 4 digits of their gene ID. Tb2430: Tb927.2.2430; Tb2440:
Tb927.2.2440; Tb1510: Tb09.211.1510. (B) TbRAP1 ChIP was performed in
VSG9-expressors or VSG2-expressors and enrichment of various ES-linked
VSGs (active and silent) was calculated as percentage of input. Protein G beads
without any antibody was used as the negative control.
A TbRAP1 ChIP was performed to follow the same VSG gene across multiple
BF cell lines in which this VSG is either fully active or silent. We discovered that
enrichment of the VSG DNA in the ChIP product is always lower in cells where it
is fully active than in cells whe re it is silent. For example, e nrichment of VSG9
DNA in VSG9-expressors is always lower than that in two independent cell lines
where VSG9 is silent (figure 3-14 A). Similarly, enrichment of VSG2 is always
lower in VSG2-expressors compared to that in cells where VSG2 is silent (figure
3-14 A). A ChIP experiment was also done to test binding of TbRAP1 to active
and silent ES-marked telomeres within the same cell line. Similar results were
obtained with this approach. We found that enrichment of VSG9 (active) was less
compared to VSG 2, 14, 18, and 6 (silent) in VSG9-expressors (figure 3-14 B).
Also, enrichment of VSG2 (active) was less compared to VSG 9, 3, 6, 14, and 18
(silent) in VSG2-expressors.
As a control, we randomly selected three chromosome internally located
genes, Tb927.2.2430, Tb927.2.2440, and Tb09.211.1510, and estimated the
amount of their DNA co-immunoprecipitated with TbRAP1 in the ChIP
experiment. As shown in figure 3-14 A, a very low amount of these DNAs were
detected in the TbRAP1 ChIP product. The amount of precipitated control gene
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DNA is similar to that of the active VSGs, suggesting that TbRAP1 does not
interact with the active VSGs at a significant extent.
It is not yet clear whether TbRAP1 possesses any direct DNA binding ability.
The current prevailing hypothesis is that, like hRAP1, TbRAP1 depends on its
interacting partner TbTRF to be recruited to telomeres. TbRAP1 was found to
preferentially bind to silent ES-marked telomeres. We wanted to test whether
TbTRF mediates this preferential binding of TbRAP1. If this is true, then TbTRF
will also binds preferentially more to silent ES-marked telomeres. In order to test
this possibility TbTRF ChIP was performed using an antibody against TbTRF.
The amount of the active ES-linked VSG DNA and a silent ES-linked VSG DNA
co-immunoprecipitated with TbTRF was estimated by quantitative PCR. ChIP
was performed in VSG2-expressors (VSG2 active). Enrichment of VSG2 DNA as
well as of VSG 13, 14, and 16 (silent VSGs) was estimated. Pull-down was also
calculated for two control genes (Tb927.2.2430 and Tb927.2.2440) that are
present at the chromosome internal regions.
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Figure 3-15: TbTRF binding to subtelomeric VSGs. TbTRF ChIP was performed
in VSG2-expressors and enrichment of various ES-linked VSGs (active and
silent) was calculated as percentage of input. Protein G beads without any
antibody was used as a negative control. Average values were calculated from
three independent experiments, and error bars represent standard deviation.
Control genes are listed using the last 4 digits of their gene ID. Tb2430:
Tb927.2.2430; Tb2440: Tb927.2.2440.
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TbTRF ChIP was performed in VSG2-expressors (VSG2 active). As seen in
figure 3-14, no significant difference in pull-down of active (VSG2) and silent
VSGs (VSG 13, 14, and 18) was observed, suggesting that TbTRF does not
differentially bind to silent ES-marked telomeres. Also, binding at all VSGs was
almost equal to that seen for control genes (Tb2430 and Tb2440), suggesting
that TbTRF does not bind to VSGs in significant way and the binding observed is
sequence non-specific. This result suggests that unlike TbRAP1, probably
TbTRF does not spread towards the subtelomeric region. From our previously
published IF data we know that all TbTRF foci co-localizes with telomeres.
However, not all TbRAP1 foci co-localizes with TbTRF, suggesting that TbRAP1
might be associated with non-telomeric chromatin (Li et al. 2005 and Yang et al.
2009).
TbRAP1 ChIP will have to be repeated to determine whether TbRAP1,
preferentially associates with silent ES due to several reasons: i) There is a lot of
variation in pull-down for the same VSG within different experiments, ii) In a few
cases there is not a significant difference between pull-down of the active VSG
and a silent VSG (figure 3-15 B, VSG9 and VSG2 in VSG9-exprssors). Owing to
such differences it is hard to obtain a statistically significant value, although a
clear trend does exist. More experiments may provide a clearer result.
DISCUSSION
In this study, we discovered that TbRAP1 is required for maintaining ESlinked VSG silencing in PF cells as well as in BF cells. Depletion of TbRAP1 led
to an increase in steady-state levels of VSG mRNA from several ten- to several
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hundred-fold. TbRAP1 is also required for silencing mVSGs in both PF and BF
cells. The strength of TbRAP1-mediated ES-linked VSG silencing is stronger in
PF compared to that in BF. Interestingly, steady-state mRNA levels of ES-linked
VSGs are lower in PF cells than in BF cells (silent VSGs), possibly due to
differential regulation of VSG mRNA stability by VSG 3’ UTR in PF and BF cells
(Berberof et al. 1995). However, regardless of the steady-state levels of VSGs,
the changes detected in mRNA levels upon depletion of TbRAP1 are solely due
to the silencing effect of TbRAP1. Upon depleting TbRAP1, VSG derepression
observed in PF cells was increased compared to that in the BF cells (Yang et al.
2009), indicating a stronger silencing by TbRAP1 in PF cells. This comparative
analysis was performed for only three VSGs due to limited strain availability.
However, a comparison between previously published data and current data
suggests that derepression for most of the ES-linked VSGs were higher in PF
cells. Nevertheless, during derepression, every ES-linked VSG behaved
differently and hence it is possible that for some VSG the derepression level
might be similar in PF and BF cells.
The telomeric and subtelomeric chromatin structure was affected significantly
upon depletion of TbRAP1 in PF cells but not in BF cells, indicating that TbRAP1mediated VSG silencing in PF occurs through chromatin remodeling. Many
previous studies have implied the role of chromatin modulation in regulation of
ES-expression in BF forms. It is known that the active ES is highly devoid of
nucleosomes compared to the silent ES in BF cells (Figueiredo and Cross 2010,
Stanne and Rudenko 2010). Also, several chromatin-remodeling factors, such as
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ISWI (Hughes et al. 2007, Stanne et al. 2011), DAC3 (Wang et al. 2010), Spt16
(Denninger et al. 2010), and Dot1b (Figueiredo et al. 2008) have been proven to
be important for regulating activity of the ES promoter. We now find that TbRAP1
also plays an important role in regulation of ES-linked VSGs, mVSGs, and
minichromosomes VSGs via chromatin remodeling in PF cells.
Depletion of TbRAP1 led to a change in chromatin structure at all tested
subtelomeric VSG loci. The chromatin structure change was also observed for
VSG671, which is located on a minichromosome. No change in the mRNA levels
was observed for VSG671 upon depletion of TbRAP1, possibly due to lack of an
upstream promoter. Therefore, opening up of chromatin structure at the VSG671
locus after knocking down TbRAP1 suggests that the change was not due to
elevated transcription but was rather primarily due to TbRAP1 depletion. ESlinked VSGs and mVSGs on the other hand possess upstream promoters and
hence it is possible that the changes in chromatin structure may be one of the
reasons for their derepression. FAIRE values obtained for ES-linked VSGs were
higher compared to that obtained for the VSG671 locus (P<0.05) (figure 3-11 A).
Since all ES-linked VSGs were highly derepressed it is possible that the elevated
transcription may result in an even more opened chromatin structure.
FAIRE and MNase data proved that TbRAP1 had a mild global effect on
chromatin structure as small changes were seen at chromosome internal loci as
well as at the ES promoter regions upon TbRAP1 depletion. In budding yeast,
RAP1 is known to bind at non-telomeric sites and function as transcription
regulator of multiple genes (Shore D 1994, Yarragudi et al. 2007, Teo et al. 2010,
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Martinez et al. 2010, Yang et al. 2011). In yeast depletion of Abf1 and RAP1 led
to altered nucleosome occupancy at more than a thousand loci, resulting in a
genome-wide effect (Ganapathi et al. 2011). Thus, it is possible that similar to its
yeast and human homologs, TbRAP1 determines the chromatin structure at a
global level. However, its effect on subtelomeric loci is much more significant and
robust.
“To our surprise, we did not detect significant chromatin structure changes in
BF cells on TbRAP1 depletion. Our observations suggest that the significantly
more severe chromatin structure change and the significantly stronger gene derepression at ESs in PF cells than those in BF cells are linked. Currently, we
favor several possible explanations (not necessarily mutually exclusive) for the
different phenotypes observed in BF and PF cells. First, the BES chromatin may
have different structures in BF and PF cells, and TbRAP1 may be the
responsible factor for this difference. An earlier work (Navarro et al. 1999) found
that T7 polymerase-mediated transcription from a chromosomally integrated T7
promoter is repressed along the entire length of the BES in PF cells, but not in
BF cells. Therefore, the chromatin structure at the silent BES appears to be more
tightly packed in PF cells. It is possible that TbRAP1 is the factor that maintains a
more closed BES structure in PF cells. Second, as BF cells undergo antigenic
variation and silent BESs need to be ready to switch to the active state, their
silent state is likely metastable, similar to what is often observed for telomeric
silencing in yeast (Gottschling et al 1990). Therefore, the BES may switch
between the open and closed states more frequently in BF cells than in PF cells.
In this case, TbRAP1 may still be involved in determination of chromatin
structures in BF cells, but our techniques are not sensitive enough to detect a
significant change owing to the fast switching status of the BES. Another
possibility is that more factors are involved in modulating BES chromatin
structure and BES silencing independent of TbRAP1 at the BF stage. Therefore,
depletion of TbRAP1 in BF cells may still affect the chromatin structure, but a
lesser degree of change or no quantifiable differences can be detected. Glover
and Horn showed that an rRNA promoter- driven reporter gene targeted 5 kb
from the telomere in a silent BES was expressed in PF cells, but not in BF cells
(Glover et al. 2006), suggesting that additional factors are involved in silencing
BESs in BF cells. A recent study suggested that depletion of histone H1 led to a
chromatin opening at multiple genomic loci only in BF cells, but not in PF cells
(Povelones et al. 2012), which is also consistent with this hypothesis.” (Pandya et
al. 2013)
A unique DNA base modification, β-D-glucosyl-hydroxymethyluracil (base J)
has been identified in T. brucei (Gommers-Ampt et al. 1993). Base J is present in
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BF but absent in PF (Van Leeuwen et al. 1998a) and is highly enriched at
telomeres (Van Leeuwen et al. 1998b). In T. cruzi, loss of base J led to elevated
transcription of Pol II transcribed gene, with decrease in nucleosome abundance
and increased histone acetylation (Ekanayake and Sabatini 2011). This suggests
that base J can regulate chromatin structure. It is possible that lack of chromatin
structure change observed in BF cells upon depletion of TbRAP1 could be due to
base J. In the future, depletion of base J in TbRAP1 knockdown background can
be performed to test whether there is any change in chromatin structure and any
additional elevation of VSG derepression.
TbRAP1 was found to preferentially locate with the silent ES-marked
telomere. This suggests that TbRAP1 functions in a cis-acting manner and it
physically binds to silent VSGs to maintain their regulation. The amount of
TbRAP1 associated with the active VSG was not significantly different from that
at the chromosome internal genes. This finding is in co-ordinance with the fact
that the active VSG is highly transcribed in T. brucei. TbRAP1-mediated VSG
silencing was found to be stronger in PF cells compared to that in the BF cells. In
the future, it would be interesting to perform ChIP and compare the relative
binding of TbRAP1 at VSGs in BF and PF cells. We hypothesize that; the amount
of TbRAP1 bound to ES-telomeres in PF cells would be more compared to that in
the BF cells.
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CHAPTER IV
ROLE OF TbRAP1 IN TELOMERE BIOLOGY

INTRODUCTION
Chromosome ends need to be protected from being detected as double
strand breaks from DNA damage repair machineries such as non-homologous
end joining (NHEJ) and homology-directed repair (HDR). Telomeric proteins play
a key role in the protection of the telomeres from being detected as DNA breaks
and thereby preventing deleterious consequences. Another key role of telomere
proteins is maintaining telomere length via regulating the access of telomerase to
the telomeres.
ScRAP1 is known to regulate the telomere length (Conrad et al. 1990, Lustig
et al. 1990, Kyrion et al. 1992, Liu et al. 1994, Marcand et al 1997). The
temperature sensitive alleles of ScRAP1 with a C-terminal truncation had several
phenotypes including dramatically elongated telomeres that are prone to rapid
deletions (Kyrion et al. 1992). The C-terminal domain of ScRAP1 is known to
interact with Rif1 and Rif2. Rif1 and Rif2, along with ScRAP1, contribute to
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telomere length homeostasis (Hardy et al. 1992, Wotton and Shore, 1997). The
overexpression of ScRAP1 also led to reduced chromosome stability (Conrad et
al. 1990). A “protein counting” model has been proposed in budding yeast, where
a threshold number of RAP1 molecules bound to the telomere, prevents its
further elongation by inhibiting the telomerase (Marcand et al. 1997). Mutation of
SpRAP1 in fission yeast leads to telomere elongatio n (Kanoh and Ishikawa
2001). It also regulates telomeric clustering since upon its mutation very few
telomeres cluster towards the spindle pole body at the horsetail stage (Kanoh
and Ishikawa 2001). Overexpressing hRAP1 or its domain-deletion mutation in
telomerase positive cell lines leads to telomere elongation, suggesting that like its
yeast homologs, hRAP1, also regulates telomere length (Li and De Lange 2000,
Li and De Lange 2003). Thus, it is evident that in budding yeast, fission yeast,
and humans, RAP1 has an important function in telomere length regulation.
The depletion of RAP1 also leads to the activation of various DNA damage
repair pathways in yeast and human. The conditional knock-out of ScRAP1
resulted in telomere fusions which were mediated by the NHEJ pathway (Pardo
and Marcand 2005). The C-terminal truncation of ScRAP1 culminated in rapid
chromosome loss and elevated rates of chromosome nondisjunction (Kyrion et
al. 1992). In budding yeast, non-dividing cells depend on yKu and RAP1 for
telomere capping. G0 cells lacking RAP1 had telomere degradations , suggesting
that RAP1 prevents nuclease activities at telomeres in resting cells (Momchil et
al. 2010). Surprisingly, compared to the shorter telomeres, little or no DNA
damage response was elicited at long telomeres having multiple RAP1-binding
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sites upon induction of double strand breaks, suggesting that yeast RAP1 plays a
role in telomere end concealment (Negrini et al. 2007). In Kluyveromyces lactis
disruption of RAP1 binding by altering telomeric sequences results in elevated
telomere recombination leading to the formation of t-circles (free circular
telomeric DNA molecules) (Cesare et al. 2008). hRAP1 was also implicated in
preventing NHEJ, as RAP1 artificially tethered to telomeres was able to inhibit
telomere end fusions (Bae et al. 2007, Sarthy et al. 2009). Additional evidence
came from in vitro analysis using telomeric oligos; the results showed that
TRF2/RAP1 prevented ligase IV dependent end joining (Bombarde et al. 2010).
In contrast, mouse RAP1 was implicated in preventing homology directed repair
and was not required for preventing telomere fusions (Sfeir et al. 2010, Martinez
et al. 2010). These results were confirmed using two independent approaches,
where either the RAP1 gene was deleted or by using a TRF2 mutant allele that
fails to recruit RAP1 to telomeres (Sfeir et al. 2010, Martinez et al. 2010).
Regardless of the observed differences , it is evident that RAP1 is required for
preventing activation of the DNA damage repair pathways at the telomere.
TbRAP1 was identified as a TbTRF interacting factor and was confirmed to be
an intrinsic telomeric factor (Yang et al. 2009). A role of TbRAP1 in the
transcriptional gene silencing was identified. However, not much is known about
the function of TbRAP1 in telomere end protection. The lack of recognizable
homologues of DNA ligase IV in T. brucei suggested that NHEJ is either absent
or diverged (Burton et al. 2007). However, repair through homologous
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recombination have been identified and studied in T. brucei (Alsford and Horn
2007, Barnes and McCulloch 2007, Glover et al. 2008, Glover et al 2010).
Recent work from our lab found that TbRAP1 depletion in BF cells leads to an
elevated

rate

of VSG switching

through gene conversion mechanism

(recombination based mechanism) (Nanavaty and Li, unpublished data). This
finding suggests that TbRAP1 has a role in preventing telomere recombination.
Unlike its yeast homologs, the depletion of TbRAP1 did not affect telomere length
dramatically in BF cells within two days (Li, unpublished data). However, a
decrease in the telomere G-overhang (single-stranded 3’ overhang at the end of
telomeres) signal was obtained after the knockdown of TbRAP1 in BF cells,
suggesting that it is required for protecting the G-overhang structure. The
characterization of the role of TbRAP1 in the telomere terminal structure at the
PF stage is lacking. Also, it is not clear whether TbRAP1 carries out all of these
functions via direct DNA binding. Hence, we wanted to test whether TbRAP1 has
any DNA binding activity and whether it plays any role in telomere end protection
in PF T. brucei cells.
RESULTS
The DNA-binding activity of TbRAP1
It is not known whether TbRAP1 can directly bind to the telomeric DNA in T.
brucei, similar to ScRAP1. In order to test this possibility, electrophoretic mobility
shift assay (EMSA) was performed. The TbRAP1 gene with a Kozak sequence
was cloned into the pBlueScript vector driven by a T3 promoter. The TbRAP1
protein was obtained by performing in vitro transcription (mMESSAGE
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mMACHINE ® T3 transcription kit, Thermo Fisher Scientific Inc.) and translation
(TNT® T7/T3 Coupled Reticulocyte Lysate System, Promega). GST-TbTRF
purified from E. coli was used as a positive control (Li et al. 2005).
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Figure 4-1: EMSA to test DNA-binding activity of TbRAP1. (A) TbRAP1 was
obtained by performing in vitro transcription and translation. The left panel shows
EtBr-stained RNA gel. A band of precise 2.6 kb for the TbRAP1 transcript was
obtained. The right panel shows a polyacrylamide gel with S 35 labeled TbRAP1
protein obtained by in vitro translation. (B) An EMSA assay was performed using
GST-TbTRF, TbRAP1 (lysate containing translated protein) and no mRNA
(lysate without TbRAP1). P 32 labeled (TTAGGG)12 probe was used. The
competitor used was nonradioactive (TTAGGG)5 probe. 100 ng of GST-TbTRF
was used. 2 µl and 5 µl of lysate with (labeled as TbRAP1) or without TbRAP1
(labeled as no mRNA) protein were used. 3.45 µg of competitor was used.
Asterisks indicate the free probe.
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In vitro transcription was performed to obtain TbRAP1 mRNA, as seen in
figure 4-1 A. After confirming the correct size, mRNA was purified and further
used for in vitro translation. Translation was performed in the presence of
radioactive S 35 to confirm successful translation of TbRAP1. The translated
product was seperated on a polyacrylamide gel, which was dried and exposed to
a phosphorimager screen. A faint band of ~150 kDa corresponding to TbRAP1
was obtained, indicating that TbRAP1 was not translated at a very abundant
level. We further used the translation product for EMSA. No mRNA sample was
used as a control. S35 was also added to no mRNA sample for better comparison.
A recombinant partially purified GST-TbTRF is known to directly bind TTAGGG
repeats in vitro and was used as a positive control (Li et al. 2005). As previously
published, GST-TbTRF binds the duplex TTAGGG repeat (figure 4 -1 B lane 2),
and the GST-TbTRF/telomere DNA complex can be competed by adding nonradioactive TTAGGG duplex DNA probe, indicating that the binding is specific
(figure 4-1 B lane 3). Mixing in vitro translated TbRAP1 with the duplex telomere
DNA probe resulted in several bands on the polyacrylamide gel (figure 4-1 B lane
4 and 5 depicted by solid black dot). However, these bands did not disappear
upon adding cold competitors (figure 4-1 B lane 6 and 7), suggesting that the
observed bands my not be complexes formed specifically between TbRAP1 and
the double stranded TTAGGG repeats. Since in vitro translated TbRAP1 is
radiolabeled, it is possible that one observed band in the polyacrylamide gel was
free TbRAP1 protein. Hence, we decided to perform another binding assay by
using unlabeled TbRAP1 protein.
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Figure 4-2: EMSA by using unlabeled TbRAP1 protein. (A) EMSA was performed
by using GST-TbTRF, unlabeled TbRAP1 and unlabeled empty mRNA. P32
labeled (TTAGGG)12 probe was used to test the binding. The competitor used
was nonradioactive (TTAGGG)5 probe. 100 ng GST-TbTRF was used. 5 µl of
lysate with (labeled as TbRAP1) or without TbRAP1 (labeled as no mRNA)
protein was used. 3.45 µg of competitor was used. (B) EMSA was performed
using S35 labeled TbRAP1 or no mRNA sample. The bold arrow represents free
radiolabeled TbRAP1 protein.
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Using unlabeled or labeled TbRAP1 containing lysate, EMSA was performed.
As seen in figure 4-2 A, a shift was observed for GST-TbTRF that was competed
out using competitor, thus suggesting specific binding of TbTRF to TTAGGG
repeats. Interestingly, we did not observe the shifted bands on gel upon using
unlabeled TbRAP1 protein, which we previously observed. However, a smear
was seen on the gel probably due to interference from the lysate (which is known
to contain huge amount of globin proteins). Interestingly, the bands reappeared
on the gel when EMSA was performed using radiolabeled TbRAP1 (figure 4-2 B,
bold arrow). This suggests that, the bands observed on the gel were due to free
radiolabeled TbRAP1 protein. Thus it seems that TbRAP1 does not possess
DNA binding activity. However, due to interference of lysate with free probe
migration and due to very low levels of TbRAP1 translation, it is difficult to reach
any clear conclusions at this point.
TbRAP1 and telomere length regulation
In BF cells, it is known that the telomere length is not affected upon TbRAP1
depletion within two days. Southern blot analysis was performed to determine if
TbRAP1 plays any role in telomere length regulation in PF cells. Genomic DNA
was collected before and after depletion of TbRAP1 and digested with the
frequent DNA cutters, AluI and MboI. After digestion, chromosome internal
genomic DNA was digested into small fragments leaving only the telomeric tracts
intact. The digested genomic DNA was then separated on an agarose gel where
most chromosome internal DNA fragments were run off the gel. The larger sized
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telomeric DNA fragments were subsequently blotted onto a nylon membrane
followed by hybridization with a telomere specific probe.
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Figure 4-3: Telomere Southern blot in PRi-pool cells. Protocol for performing the
telomere Southern blot is described on the left. On the right the result of
hybridization with a telomere specific probe is shown. Genomic DNA was
collected before (day 0) and after (day 2 and 3) depletion of TbRAP1 in PRi-pool
cells (PF cells). The parent cell line not carrying the RNAi vector was used as a
control.
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As seen from figure 4-3, no change in the telomere length was observed upon
depleting TbRAP1 in PF cells within 3 days. The telomere length in T. brucei
ranges from 2-12 kb. Telomere fragments of 3 kb to more than 12kb were
observed for PRi-pool cells when the bulk telomeres were detected by a
TTAGGG repeat probe. No apparent change in size of the telomere fragments
was observed, indicating that TbRAP1 depletion does not affect telomere length
in PF cells. However, if TbRAP1’s effect on telomere length is subtle then it will
be hard to capture in the bulk telomere Southern blot. Hence, we decided to
follow a single telomere and analyze its length before and after depletion of
TbRAP1, by performing terminal restriction fragment (TRF) analysis. T. brucei
telomeres are marked with unique VSG genes at subtelomeric loci, which allows
us to measure length change at individual telomeres. Genomic DNA was
digested with restriction enzymes that cut specifically upstream of a particular
VSG gene, releasing a terminal restriction fragment containing the VSG gene
and its downstream telomere. This TRF can be visualized on a Southern blot by
hybridization with the VSG specific probe.
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Figure 4-4: Terminal restriction fragment analysis to measure telomere length in
PRi-pool cells. Genomic DNA was collected before (day 0) and after (day 2 and
3) depletion of TbRAP1 and digested with EcoRI. Southern blot analysis was
performed and blots were hybridized with (A) VSG2 and (B) VSG9 specific
probes. Left panel shows EtBr-stained gel, while right panel shows the hybridized
Southern blot. Arrowheads indicate telomeric fragments containing VSG2 and
VSG9.
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Two VSG-marked telomeres were tested. As seen in figure 4 -4 A, the size of
the VSG2 TRF remained unchanged, suggesting that the telomere length is not
affected upon depletion of TbRAP1 within a short frame of time. Similar analysis
was done for telomere associated with VSG9. Unlike VSG2, which is a single
copy gene, VSG9 have two copies in the genome and two DNA bands were
observed on the gel. Although the loading of genomic DNA was unequal between
different samples (figure 4-4 B left panel), no change in the size of the VSG9containing fragments was observed (arrowheads in figure 4-4 B right panel). We
also tested the VSG11-marked telomere and similar results were obtained (data
not shown). Thus from the bulk telomere southern blot (figure 4-3) and terminal
restriction fragment analysis (figure 4-4) it was evident that TbRAP1 does not
affect telomere size in PF cells within three days.
G-overhang structure analysis
Since telomere length was not affected upon depletion of TbRAP1, we wanted
to test whether the telomere G-overhang structure is affected. T. brucei
telomeres end in a 3’ overhang (containing TG repeats). The telomere complex
protects the G- overhang in mammals (de Lange 2005).
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Figure 4-5: In-gel hybridization analysis of the telomere G-overhang in PRi-pool
cells. (A) DNA plugs were prepared before (day 0) and after (day 2 and 3)
depletion of TbRAP1. Plugs were also prepared from the parent cell line without
any RNAi construct. Intact chromosomes were separated by pulsed filed gel
electrophoresis as seen in EtBr-stained gel (left panel). The gel was dried and
hybridized with an end-labeled (CCCTAA)4 oligo probe either before (middle
panel) or after (right panel) denaturation of the gel. Arrowheads indicate the
signal from the minichromosomes. (B) An average of quantification of the G115

overhang signal calculated from two independent experiments. The relative Goverhang signal was calculated for either da y 2 or day 3 by dividing their signals
to that of the day 0 signal.

DNA plugs were prepared from induced and uninduced PRi-pool cells. A
parent cell line devoid of any RNAi construct was used as a control. Intact
chromosomes were separated using Pulse Field Gel Electrophoresis (PFGE).
The T. brucei genome consists of ~100 minichromosomes. Under our
electrophoresis conditions, they all migrate at the same position. The telomere Goverhang signal is therefore most prominent at minichromosomes and is used for
calculation (arrowheads in figure 4 -5 A). To detect the G-overhang signal, the
native gel was first hybridized with the (CCCTAA)4 probe and the signal was
quantified (figure 4-5 A middle panel). The same gel was subsequently
denatured and hybridized with the same probe and the signal quantified again
(figure 4-5 A right panel). The G-overhang signal is therefore calculated by
dividing the amount of the native hybridization signal by that of the hybridization
signal after denaturation. After obtaining the G-overhang signal for each sample,
relative G-overhang levels were calculated by dividing values of day 2 and day 3
with the value of day 0. As seen in figure 4-5 B, a 20% reduction in G-overhang
signal was seen by day 2 upon inducing RNAi against TbRAP1. By day 3, only
~30% of the G-overhang signal was left. Thus, we concluded that TbRAP1 is
required for protecting the telomere G-overhang structure in PF cells.
DISCUSSION
EMSA analysis suggested that TbRAP1 does not bind to the telomeric DNA
directly. However, the experiment encountered certain technical difficulties. The
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Rabbit Reticulocyte Lysate system used for translation contains a huge amount
of globin protein. These proteins present in the binding reaction interfered with
the migration of the probe, making it difficult to interpret the results. Also, the in
vitro translated TbRAP1 was in a very low amount. In the future, translation can
be done using a baculovirus expression system to obtain higher amounts of
translated protein. The full length GST-TbRAP1 is not soluble when expressed in
E. coli. Instead of full-length recombinant protein, only the C-terminal half of
TbRAP1 can be expressed in E. coli with reasonable solubility. We are currently
working on solving the NMR structures of TbRAP1 myb and myb-like domains in
collaboration with Dr. Yanxiang Zhao at Hong Kong Polytechnic University. This
will help reveal whether TbRAP1 has any sequence-specific DNA binding
activities.
Telomere length seems to be unaffected upon depleting TbRAP1 in PF cells,
at least within a short frame of time. TbRAP1 knockdown leads to growth arrest
within 72 hours in the PF cells and within 24 hours in the BF cells. The decrease
in telomere size due to the absence of telomerase activity is 3-6 bp/population
doubling (Dreesen et al. 2005). It is possible that we do not observe telomere
length change due to a limited time window before the cells arrest upon TbRAP1
depletion. In the future, viable point mutants of TbRAP1 can be used to further
analyze its role in telomere length maintenance. Overexpression of hRAP1 led to
telomere elongation (Li and De Lange 2000, Li and De Lange 2003). TbRAP1
can presumably be overexpressed in order to study its role in telomere
maintenance, although attempted overexpression of TbRAP1 led to massive
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degradation of the ectopic TbRAP1 allele (data not shown). If TbRAP1 does not
have any telomere DNA binding activity, it will depend on TbTRF to be recruited
to the telomere. Establishing TbTRF mutants with weakened interaction with
TbRAP1 (described in chapter V) can also be helpful in elucidating TbRAP1’s
function in telomere length regulation.
TbRAP1 depletion affects G-overhang structure in PF cells. A 70% loss of Goverhang signal was observed by day 3 of TbRAP1 RNAi induction, suggesting
that TbRAP1 is required for the chromosomal end protection. Deprotection of
telomeres in mammalian cells leads to DNA damage responses and results in
activation of ATM/p53 dependent apoptosis or senescence-like cell cycle arrest
(Van steensel et al. 1998, Karlseder et al. 1999, Takai et al. 2003). Since we
observed growth arrest upon TbRAP1 depletion, it is possible that this
deprotection at telomeres (loss of G-overhang) might elicit a DNA damage
response.
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CHAPTER V
FUNCTIONAL ANALYSIS OF TbTRF

INTRODUCTION
TbTRF functions in telomere end protection
TbTRF (Tb10.389.0680) was identified as a component of the telomere
complex, and it directly binds to the telomeric DNA in T. brucei (Li et al. 2005).
TbTRF is an essential protein, and cells stop proliferating after TbTRF depletion
within 24 (in BF cells) or 48 hours (in PF cells). TbTRF depletion in T. brucei did
not affect ES-linked VSG silencing (Yang et al. 2009, Pandya et al. 2013).
However, TbTRF is required for the protection of the telomere G-overhang
structure (Li et al. 2005). Due to this acute growth arrest upon knockdown of
TbTRF, it is difficult to define all of the functions of TbTRF at the telomere.
Hence, identification of viable mutants of TbTRF would be very useful for
characterization of all its roles at telomeres.
TbTRF contains a C-terminal myb domain that is required for DNA binding
and a TRF homology (TRFH) domain towards the N-terminus that is essential for
homodimerization (Li et al. 2005).

.
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The TbTRFH domain also interacts with TbRAP1 (Yang et al. 2009) and TbTIF2
(Jehi et al. 2014), suggesting its role in recruitment of other telomeric proteins.
Hence, the TbTRFH domain is critical for several functions at the telomeres.
Similarly, in mammalian cells, TRF1 forms a homodimer via its TRFH domain
and binds to telomere DNA through its C-terminal myb domain (Bianchi et al.
1997). The TRFH domain of TRF1 is required for recruiting another telomere
protein, TIN2, to the telomeres (Kim et al. 1999, Houghtalin et al. 2004). It was
discovered that the TRFH domain of TRF1 is not only required for protein-protein
interaction and for recruitment of telomere proteins, but it is also required for
stabilizing the telomere structure. Disruption of this domain led to an abnormal
telomere structure, such as broken or lost telomeres (Okamoto and Shinkai
2009). We are, therefore, interested in obtaining viable mutants of TbTRFH
domain that would allow us to dissect its role in protein-protein interaction as well
as its function in maintaining telomere structure integrity.
Dr. Bibo Li predicted the secondary structure of TbTRFH domain by using
PHD (service to predict the secondary structure of protein based on the
sequence information) and 3D-PSSM (software to predict the 3D structure of a
protein by matching it with existing database of available 3D structures of other
proteins). It was predicted that TbTRFH contains seven α-helices. This is very
similar to the secondary structure of mammalian TRFH domain of TRF1 and
TRF2, which consists of 9 α-helices (Fairall et al. 2001).
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Figure 5-1: The domain structure of TbTRF. TbTRF contains two domains: (i) a
TbTRFH (homodimerization) domain and (ii) a myb domain (DNA binding
domain). Software prediction suggested that the TbTRFH domain consists of
seven helices. The amino acid sequence of the TRFH domain is marked in
orange. The seven predicted helices are marked in blue.
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Deleting large fragments of the TbTRFH domain can lead to abrogation of its
homodimerization function, which is essential for the TbTRF’s telomere DNA
binding activity; normally, at least two myb repeats are required for DNA
recognition. Hence, we decided to perform subtle mutations by disrupting
individual helices to study the effects of mutants on TbTRF homodimerization
and protein-protein interaction. Our goal was to identify mutants that cannot
interact with the wild type TbTRF or other telomere proteins but can form
homodimers. Such mutants, when expressed in vivo, will be able to bind
telomeric DNA but will probably be defective in other protein-protein interactions.
This will give us information regarding functions of TbTRF in telomere protein
complex formation.
Roles of TRF in chromatin modulation
Apart from its role in telomere end protection, there has been evidence that
TRF also plays an important role in chromatin compaction and remodeling. The
overexpression of TRF2 in mice led to decreased heterochromatin marks at
telomeres and subtelomeres, a decrease in abundance of core nucleosomes,
and an increase in nucleosomal spacing at the telomeres (Benetti et al. 2008,
Galati et al. 2012). In another instance, an in vitro biophysical analysis of TRF2
and telomeric nucleosome fibers determined that TRF2 could promote folding of
these fibers and also increase their compaction, thus suggesting its role in
chromatin remodeling (Baker et al. 2009, Baker et al. 2011, Poulet et al. 2012).
Interestingly, in vitro analysis suggested that TRF1 can form a ternary complex
with the telomeric DNA bound nucleosomes and can alter its structure,
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suggesting that TRF1 can modulate chromatin structure at telomeres (Galati et
al. 2006). Also, it is known that TRF2 interacts with TERRA (telomeric transcript),
which further facilitates ORC recruitment and heterochromatin formation at
telomeres (Deng et al. 2009). Thus, it is evident that along with RAP1, TRF also
plays a role in chromatin modulation at telomeres.
Knockdown of TbTRF does not lead to ES-linked VSG derepression (Li et al.
2005). However, it is possible that TbTRF may play a secondary role in VSG
silencing by inducing chromatin compaction. Our goal was to test whether TbTRF
possess any chromatin remodeling activity at T. brucei telomeres.

RESULTS
Establishing TbTRFH domain mutants
We wanted to identify interaction-deficient mutants by performing yeast 2hybrid analysis. The TbTRF gene containing a single helix (in TbTRFH domain)
deleted at a time was amplified and cloned in the lexA vector.
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Figure 5-2: Strategy of making TbTRFH deletion mutants. pBTM116 (LexA)
vector containing wild type TbTRF was used for PCR amplification (top). Mutants
with individual helices deleted were cloned in pBTM116 vector (bottom). H
represents HindIII sites. Black bar represents PCR products generated for each
helix.
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As shown in figure 5-2, fragments upstream and downstream of the helix to
be deleted were generated using PCR amplification. Both fragments were then
simultaneously ligated into vector to obtain LexA-fused mutant TbTRF. Thus the
TbTRF gene was obtained containing a single helix deleted in the TbTRFH
domain. This protocol was repeated for each helix.

Analyzing TbTRFH mutant interactions
All the mutants were further transformed in the yeast L40 reporter strain along
with the wild-type GAD-fused TbTRF protein. After transformation, a liquid ONPG
assay was performed to test interactions between mutants with wild-type TbTRF
protein. β-galactosidase activity were measured in order to estimate the lacZ
reporter gene expression level. Interaction of wild type LexA-fused TbTRF with
GAD-fused TbTRF was used as a positive control while the interaction between
two empty vectors was used as a negative control.
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Table 2: Interaction of TbTRFH mutants with the wild-type TbTRF protein. βgalactosidase activities were measured by performing liquid assay containing
ONPG as the substrate. Values were calculated for interactions between each
mutant and the wild type full-length TbTRF protein, as well as with the empty
vector. Each value is calculated from nine independent experiments +/- standard
deviations. LEX ABD, Lex A binding domain; GAD, Gal4 activation domain.
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As seen in Table 2, deletion of helix 1, 2, 3, and 7 did not affect their interaction
swith the wild type TbTRF protein, suggesting that these helices are not required
for homodimerization of TbTRF. Deletion of helix 4, 5, and 6 affected interaction
with the wild type TbTRF to different degrees. Helix 5 deletion seems to have
weakened interaction with TbTRF compared to full-length protein. Expression of
helix 4 deletion mutant was decreased compared to other mutants and hence
that could possibly lead to a dramatically decreased interaction with the wild type
TbTRF (data not shown).
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Table 3: TbTRFH mutant-mutant self-interaction. β-galactosidase activity units
were measured by performing liquid assay containing ONPG as the substrate.
Values were calculated for interaction of each mutant with itself as well as with
the empty vector. Each value is calculated from nine independent experiments
+/- standard deviations. LEX ABD, Lex A binding domain; GAD, Gal4 activation
domain.
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Next, we wanted to test mutant-mutant self-interaction. Each TbTRF mutant
was amplified from the pBTM116 vector using primers having BamHI and XhoI
restriction sites and cloned into the pACT2 (GAD-fused) vector. Hence, we
obtained each mutant fused with Le xA and GAD. These mutants were cotransformed in the L40 yeast strain. Liquid ONPG assay was performed to test
their interaction. Interaction of LexA-fused wild type TbTRF with GAD-fused wild
type TbTRF was used as a positive control, while interaction between two empty
vectors was used as a negative control. As seen in table 2, helix 4, 5, 6, and 7
mutants had a significantly decreased self-interaction activity while helix 1, 2, and
3 mutants were dispensable for self-interaction. Again, the loss of interaction
observed for helix 4 could be due to its low expression level in yeast. From both
yeast 2-hybrid experiments it is evident that helix 4, 5, 6, and 7 are required for
homodimerization of TbTRF.
Function of TbTRF in chromatin remodeling
Initially, it was established that depletion of TbTRF does not affect ES-linked
VSG silencing in PF (unpublished data) and BF cells (Yang et al. 2009). From
our studies, it is evident that TbRAP1 is a major regulator of VSG silencing and
that it regulates this silencing via chromatin remodeling in PF forms. It is possible
that TbTRF may also play an important role in VSG silencing. However, due to
acute growth arrest upon its depletion the phenotype might not be evident.
Mammalian TRF1 and TRF2 possess the ability to compact telomeric chromatin
and form higher order chromatin structure. Hence, it was logical to test TbTRF’s
function in chromatin modulation. In order to investigate this, FAIRE analysis was
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performed in TbTRF RNAi cells in PF and BF cells. By performing quantitative
PCR using specific primers, changes in chromatin structure of ES-linked VSGs
were determined.

Figure 5-3: FAIRE analysis in TbTRF RNAi cells. FAIRE was performed in (A)
PF/TbTRF RNAi cells, (B) PF/Vector control cells, (C) BF/TbTRF RNAi cells and
(D) BF/Vector control cells. Samples were collected before (0 hr in PF and BF
cells) and after (48 hr in PF and 24 hr in BF cells) depletion of TbTRF.
Quantitative PCR was done using primers specific to indicated gene loci. Fold
change was calculated from four independent experiments and standard
deviation was calculated. Control genes are indicated with the last four digits of
their ID. Tb927.2.2430, Tb927.2.2440, Tb09.211.1510.
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Upon depletion of TbTRF in PF cell, a 5-7 fold of increased enrichment of ESlinked VSGs (VSG 2, 14 and 18) was observed (figure 5-3 A). This difference
was significantly different than observed in the vector control cells (P<0.05, figure
5-3 B). Enrichment of three chromosomal internal genes was also tested as a
control. Increase in enrichment of VSG2 and VSG18 was significantly different
from that of Tb927.2.2440 (P<0.05), suggesting that TbTRF has a mild but
significant effect on the chromatin structure of the ES-linked VSGs. Also,
changes observed at chromosome internal genes after depletion of TbTRF were
significantly different compared to that in the vector control cells , indicating that
TbTRF depletion might have a mild effect on global chromatin structure (figure 53 A and B).
Strikingly, depletion of TbTRF had no effect on chromatin structure of ESlinked VSGs in BF cells. The increase in enrichment after depletion of TbTRF in
BF cells was not significantly different than that in the vector control cells (figure
5-3 C and D). Thus, TbTRF only affects chromatin structure of ES-linked VSGs in
PF cells but not in the BF cells.
We subsequently wanted to test whether TbTRF depletion had any effect on
regulation of mVSGs. Derepression of mVSGs upon depletion of TbTRF in PF
cells was tested before analyzing changes in chromatin structure.
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Figure 5-4: Quantitative RT-PCR and FAIRE analysis of mVSGs in PF TbTRF
RNAi cells. Fold change in steady state mRNA levels of mVSGs upon induction
were tested in (A) PF/TbTRF RNAi cells and (B) PF/Vector cells. Samples were
collected before (day 0) and after (day 2 and 3) adding doxycycline. Fold change
in steady state mRNA levels for day 2 and 3 were calculated by normalizing
against day 0 value (not shown). Values for three independent experiments are
depicted. FAIRE analysis was performed to determine change in the chromatin
structure of mVSGs in (C) PF/TbTRF RNAi cells and (D) PF/Vector cells.
Samples were collected before (day 0) and after (day 2 for TbTRF RNAi, day 3
for vector control) induction. Quantitative PCR was performed using specific
primers for indicated loci in order to calculate the fold change. Fold change was
calculated by dividing values obtained post depletion with that of the values
obtained pre-depletion. Values were calculated from four independent
experiments. Bar represents standard deviation.
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After depletion of TbTRF in PF cells, steady state levels of mVSGs mRNA
were measured. No derepression of mVSGs was observed in PF/TbTRF RNAi
cells compared to the vector control cells (figure 5 -4 A and B). Hence it is
established from current studies and previously published data that TbTRF does
not play a role in ES-linked VSG or mVSG silencing. However, derepression
analysis of mVSGs upon depletion of TbTRF in BF form still remains to be
tested. FAIRE analysis was performed to determine whether there are any
changes in chromatin structure of mVSGs upon depletion of TbTRF in PF cells.
Quantitative PCR was performed to measure relative e nrichment of mVSG
specific DNA after depletion of TbTRF. A 10-16 fold enrichment of mVSGs DNA
was observed after knockdown of TbTRF in PF cells (figure 5-4 C). This
enrichment was significantly different from the chromosome internal gene used
as a control (Tb927.2.2440) as well as from the vector control cells (figure 5-4 D).
Thus, TbTRF influences telomere/subtelomere chromatin structure and its
depletion lead to opening up of the chromatin structure at ES-linked VSGs and
mVSGs in PF cells.
DISCUSSION
Due to acute growth arrest upon depletion of TbTRF, it was difficult to reveal
all the functions of TbTRF, especially in telomere structure maintenance and
protection. Therefore, establishing viable mutants of TbTRF was pivotal. TbTRFH
domain is deemed to be important for its role in TbTRF self-dimerization as well
as in interaction with other telomeric proteins, such as TbRAP1 and TbTIF2. Our
goal was to establish several helix deletion mutants of TbTRFH domain that
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would affect TbTRF homodimerization or its interaction with other telomere
proteins. Seven deletion mutants were generated and their interaction with wildtype TbTRF as well as self-interaction was tested in vitro by yeast 2-hybrid
analysis. It was established that Helix 4, 5, 6, and 7 are important for
homodimerization of TbTRF while helix 1, 2 and 3 are dispensable. These results
were very exciting since it suggested that not all helices are required for TbTRF
homodimerization and few may be utilized for interaction with other proteins.
Yeast 2-hybrid analysis can be further performed to test interaction of TbTRFH
mutants with TbRAP1 and TbTIF2 to determine which helices are involved in
these interactions. It is possible that a similar set of helices might also interact
with other telomeric proteins. If that is the case, then how does TbTRF regulate
the formation of telomere complex? Do they compete with each other for binding
at telomeres? These will be a few interesting questions to answer. If distinct
helices are used for different interactions then separation of function mutants can
be obtained. These mutants will be very valuable in elucidating role of TbTRF as
well as other telomeric proteins in telomere end regulation. So far the mode of
recruitment of TbRAP1 and TbTIF2 to the telomeres is unknown. Mutants
defective in binding to TbRAP1 and TbTIF2 can be utilized to test their binding to
telomeres.
Mutants that are able to self-dimerize can be knocked-in to replace the unique
wild-type TbTRF allele in a TbTRF single-allele knockout background. As long as
the mutants are capable of performing essential functions of TbTRF, the cells
should be viable. These mutants can be further used to study the role of TbTRF
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in recruiting other telomeric proteins and also its role in telomere structure
maintenance.
Helix 4 deletion had a dramatic effect on expression of TbTRF protein in
yeast. It is possible that its deletion could affect proper folding of TbTRF protein.
Hence, point mutations can be made in this helix to study the role of helix 4 in
homodimerization. Since

helix 1, 2 , and

3

are

dispensable

for the

homodimerization of TbTRF, simultaneous deletions of more than one helix can
also be made to further analyze critical functions of TbTRF.
Telomeric proteins are known to be involved in telomere heterochromatic
structure formation/maintenance. Our aim was to determine whether TbTRF had
any role in VSG silencing by chromatin compaction. TbTRF depletion does not
lead to ES-linked VSG derepression in PF and BF cells (Yang et al. 2009). Our
studies further established that TbTRF is not required for mVSG silencing in PF
cells. Interestingly, depletion of TbTRF does affect chromatin structure of ESlinked VSGs and mVSGs in PF cells. In contrast, similar to TbRAP1, no effect on
chromatin structure was observed in BF cells after depletion of TbTRF.
Monoallelic VSG expression is of crucial importance in BF cells. Hence, it is
possible that additional mechanisms other than telomeric proteins may play
important roles in VSG silencing. Elucidating these mechanisms can further shed
light on chromatin structure differences in PF and BF cells.
TbTRF is a DNA binding protein. It seems that TbTRF holds the telomeric
complex together and maintains its integrity. This observation explains the acute
growth arrest observed upon its depletion compared to TbRAP1 (Yang et al.
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2009, Pandya et al. 2013) and TbTIF2 (Jehi et al., 2014). For VSG derepression
to occur, a certain level of functional transcriptional machinery is required. It is
possible that the whole telomere complex may fall apart upon TbTRF depletion,
stalling all the machineries in cell. In the future, domain mutants of TbTRF can be
used to study its function in VSG regulation.
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CHAPTER VI
CHARACTERIZATION OF TRYPANOSOMA BRUCEI TELOMERIC
TRANSCRIPT: TERRA

INTRODUCTION
Telomeres were long considered transcriptionally silent due to their repressive
chromatin structure This dogma was overcome with the discovery of telomeric
transcription called TERRA: telomeric repeat containing RNA. Telomere
transcription was first identified in birds, trypanosomes, and diptera (Morcillo et
al. 1988, Rudenko & Ploeg 1989, Solovei et al. 1994). Till this date TERRA has
been identified in humans, rodents, budding yeast, fission yeast, and zebra fish
(Azzalin et al. 2007, Luke et al. 2008, Schoeftner and Blasco 2008, Greenwood
and Cooper 2011).
In mammals, TERRA is transcribed from the C-rich strand, giving rise to
UUAGGG repeats with sizes ranging from 100 bp-9 kb (Azzalin et al. 2007). In
trypanosomes TERRA is also transcribed from the C-rich strand ranging from
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0.5-4 kb (Rudenko and ploeg 1989). In budding yeast its size is usually <500 bp.
Along with TERRA, budding yeast also expresses molecules called ARRET that
are antisense to the subtelomere and do not contain any detectable telomeric
repeats (Luke et al. 2008). On the other hand, the transcriptome of fission yeast
is much more complicated and contains multiple transcripts namely TERRA,
ARRET, ARIA, and αARRET (Bah et al. 2012).
TERRA is transcribed by RNA polymerase II in humans, mouse, and budding
yeast (Schoeftner and Blasco, 2008, Luke et al. 2008). In trypanosomes,
however, it is established that TERRA transcription is not sensitive to α-amanitin,
suggesting that it is transcribed by RNA polymerase I (Rudenko and Ploeg
1989). A portion of TERRA is poly-adenylated in human, yeast, and
trypanosomes (Rudenko and Ploeg 1989, Azzalin and Lingner 2008, Luke et al.
2008). In humans, a CpG island consisting of “61-29-37” repeats located in the
subtelomeric region is the promoter for TERRA transcription, and TERRA is
found mostly in the nucleus co-localizing with telomeres (Azzalin et al. 2007,
Schoeftner and Blasco 2008, Nergadze et al. 2009).
Not only does TERRA co-localizes physically with telomeres, but also it
interacts with telomeric proteins, such as TRF1, TRF2, and ORC subunits in vivo
in mammalian cells. TERRA interaction with several heterochromatin associated
factors including heterochromatin protein 1 (HP1) and H3K9 methyltransferases
has also been established (Deng et al. 2009). Telomeric proteins are known to
play a role in regulation of TERRA levels. In budding yeast, Rap1/Sir and
Rap1/Rif complexes regulate TERRA transcription, and TERRA levels are
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upregulated upon introducing Rap1 mutant that fails to recruit Sir proteins
(Iglesias et al. 2011). In fission yeast, deletions of Taz1 or Rap1 lead to
upregulation of TERRA transcription (Greenwood and Cooper 2011). Thus , it is
clear that telomeric proteins are important in regulation of TERRA expression.
Functions of TERRA are not well characterized. Depletion of TERRA RNA
using siRNA led to loss of cell viability and formation of telomere dysfunction
induced foci (TIFs) in mammalian cells (Deng et al. 2009). Interestingly, depletion
of TERRA also affected telomere heterochromatin with reduced recruitment of
ORC and decreased amount of H3K9 trimethylation (Deng et al. 2009). This
observation suggests that TERRA might have a role in regulating telomere
heterochromatin. However, further studies are needed in order to rule out
possible secondary effects from siRNA.
T. brucei telomeres are unique in terms of the presence of VSG genes at
subtelomeres. From our studies with TbRAP1, we determined that de-repression
of silent VSGs is linked to chromatin compaction. Thus, it is possible that TERRA
may be involved in VSG silencing regulation via chromatin remodeling. This
hypothesis makes TERRA an excellent candidate to study regulation of antigenic
variation in T. brucei. Mammalian telomeres are gene-less, making them
unsuitable for studying telomere position effect, while many T. brucei telomeres
are marked with natural subtelomeric VSG genes. Hence, T. brucei is an
excellent model system to study functions of TERRA in telomere position effect.
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RESULTS
Characterization of TERRA in wild-type PF and BF cells
TERRA has been previously detected in T. brucei BF and PF cells (Rudenko
and Ploeg 1989). However data were shown only for PF cells. It was established
that the C-rich telomeric strand is transcribed, giving rise to the UUAGGG repeat
transcript and that this transcription is unidirectional, running 5’ to 3’ from
chromosome internal region towards the telomere. However, T. brucei
subtelomeric regions are quite plastic due to antigenic variation. The same strain
used in the previous study has been cultured in vitro for a long period of time. It’s
therefore possible that some detailed subtelomeric sequences have changed,
which might lead to variations from previously reported data on TERRA. Hence,
we decided to determine TERRA in wild-type BF (SM) and PF (WT427) cells.
Northern blot analysis was performed to detect TERRA size distribution as well
as the directionality of its transcription (Figure: 5-1 A). The northern blot was
hybridized with either the radioactively labeled (*CCCTAA)133 or (*TTAGGG)133
probe.
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FIGURE 6-1: TERRA in wild-type T. brucei cells. (A) Directionality of TERRA
transcription. The C-rich strand is transcribed when transcription proceeds from
chromosome internal region towards the telomere, giving rise to UUAGGG
transcript. However, if the transcription proceeds from telomere towards
chromosome internal region, then the G-rich strand will be transcribed, giving rise
to CCCUAA transcript. (B) Northern blot analysis to detect transcription from Crich strand in BF and PF cells. The northern blot was hybridized with
radioactively labeled (*CCCTAA) 133 probe. Samples were treated with or without
RNase A. Tubulin was used as internal loading control. (C) Northern blot analysis
to detect transcription from G-rich strand in BF and PF cells. Northern blot was
hybridized with radioactively labeled (*TTAGGG)133 probe. Samples were treated
with or without RNase A. A rRNA was used as an internal loading control.*
indicates radiolabeled nucleotide.
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Northern blot analysis detected TERRA molecules ranging from the 0.5 -10 kb
in BF cells. However, in procyclic form, the size of TERRA molecules is between
0.5-1.5 kb with a major band of ~1.5 kb long. Upon RNase A treatment, signals
were lost in both BF and PF samples, indicating that the TERRA signal was
contributed specifically from the RNA and was not due to DNA contamination.
The majority of transcription in BF cells was detected when the blot was
hybridized with the (*CCCTAA)133 probe, suggesting that TERRA transcription
proceeds towards telomere ends giving rise to the UUAGGG transcript.
Transcription detected from G-strand was almost negligible in BF cells. However,
in PF TERRA was detected from both strands, suggesting that the nature of
TERRA molecules might be different in BF and PF cells. More experiments will
be required to analyze the nature of TERRA molecules in PF cells.
Interaction of TERRA with telomeric proteins
Our lab has characterized the telomeric complex of T. brucei. So far, three
telomeric proteins have been identified. TbTRF is a duplex TTAGGG repeat
binding factor, while TbRAP1 and TbTIF2 were identified as TbTRF interacting
factors. Since TERRA is transcribed from telomeres, we are curious whether
TERRA interacts with any of the known telomeric proteins in T. brucei (Figure 62). In addition, TbKU80 has been shown to play an important role in maintaining
telomere length (Janzen et al. 2004), although its mechanism is unknown. It is
possible that TbKU80 may interact with TERRA in order to regulate the telomere
length. In order to test this we performed RNA-Immunoprecipitation (RNA-IP)
assay. Various cell lines containing telomeric proteins tagged with either GFP or
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F2H (Flag-HA-HA tag) tags were used for this purpose. Pull-down of telomeric
proteins was performed using antibodies against either the GFP or HA epitope.
Co-Immunoprecipitated RNA was detected by dot blot analysis by hybridization
with telomere specific probes.
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FIGURE 6-2: Interaction of TERRA with telomeric proteins. (A) Western analysis
showing expression of various tagged telomeric proteins in BF cells. Levels of
GFP-TbTRF and GFP-TbKU80 were detected using rabbit anti-GFP antibody
(Life Technologies). A cell line expressing GFP alone was used as a negative
control. F2H-TbRAP1 and F2H-TbTIF2 were detected using an antibody against
the HA tag (F-7, Santa Cruz Biotechnology Inc.). The wild-type cell line, not
expressing any F2H tag was utilized as negative control (BF WT). (B) RNA slot
blot analysis to detect TERRA molecules co -immunoprecipitated with various
telomeric proteins. Dynabeads IgG without any antibody was used as negative
control. The blot was hybridized with radioactive labeled (*CCCTAA)133 probe. (C)
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Quantification of RNA slot blot experiments. The average of enrichment of pulldown sample over input (%) was calculated from three independent experiments.
Error bars represent standard deviation.
GFP-TbTRF showed an ~14 fold enrichment of TERRA RNA compared to
control (Fig. 6-2C), suggesting that TbTRF interacts with TERRA. Our preliminary
data showed that TbKU80 might interact with TERRA (Fig. 6-2C). The fold
enrichment observed is much less compared to that obtained for TbTRF,
however, it is ~5 fold more compared to no antibody control. More experiments
are needed to confirm whether this result is reproducible. F2H-TbRAP1 does not
interact with TERRA, as the fold enrichment is almost similar to negative control
(when IP using the HA antibody was done in wild-type cells carrying no F2H tag)
(Fig. 6-2C). F2H-TbTIF2 IP showed elevated levels of TERRA enrichment that
was not significantly different from the negative control due to large variations,
suggesting that TbTIF2 does not interact with TERRA (Figure 6-2C). All the IP
samples were treated with DNase I, suggesting that the signal obtained on slot
blot is due to RNA. However, additional controls such as RNase A treatment
before IP needs to be done. Based on our current preliminary observations, we
conclude that TbTRF and TbKU80 interact with TERRA while TbRAP1 and
TbTIF2 do not interact with TERRA RNA.
Regulation of TERRA levels by telomeric proteins
TERRA expression is influenced by telomeric protein in yeast (Greenwood
and Cooper 2011). We therefore wanted to test whether any of the known
telomeric proteins in T. brucei plays any role in regulation of TERRA levels. We
depleted individual telomeric proteins by RNAi in different inducible telomeric
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protein RNAi strains. Upon induction of RNAi using doxycycline, knockdown of
TbTRF, TbRAP1, and TbTIF2 was confirmed by western blotting. Imaan
Benmerzouga performed TbTRF western blot analysis and Sanaa Jehi did
TbTIF2 western blot analysis. Total RNA was isolated before and after depletion
of individual telomeric protein. Northern blot analysis was performed using the
(*CCCTAA)133 probe in order to detect changes in TERRA levels and sizes. Since
TERRA molecules have a large size distribution and it is hard to estimate the
total amount of TERRA from the northern blot, we also performed slot blot
analysis to quantify changes in the TERRA levels.
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FIGURE 6-3: Regulation of TERRA RNA level by telomeric proteins. (A) Western
blot analysis to determine knockdown of TbRAP1, TbTRF, and TbTIF2 in BF
cells. Whole cell lysate was collected before (0 hour) and after (24 hours for
TbRAP1 and TbTRF, 30 hours for TbTIF2) (B) Northern blot analysis to detect
levels and distribution of TERRA before and after depletion of TbRAP1, TbTRF
and TbTIF2. Cells transfected with an empty RNAi vector was used as a negative
control. RNA was collected before (-) and after (+) doxycycline induction (24
hours for TbRAP1 and TbTRF, 30 hours for TbTIF2. The blot was hybridzed with
the (*CCCTAA)133 probe. rRNA precursors are shown as a loading control. (C)
Slot blot analysis to quantify changes in TERRA level. The blot was hybridzed
with the (*CCCTAA)133 probe. Hybridization to the tubulin probe was used as an
internal loading control. (D) Quantification of slot blot analyses. Fold changes in
TERRA amount was calculated by dividing post-induction TERRA signal intensity
by pre-induction signal intensity. Standard deviations are shown as error bars. P
values of unpaired t-tests were calculated compared to control cells from four
independent experiments.
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Northern analysis was performed to compare the TERRA levels and
distribution before and after depletion of TbRAP1, TbTRF, and TbTIF2. We
observed that the steady state level of TERRA RNA increased upon depletion of
all telomeric proteins compared to the control cells transfected with an empty
RNAi vector (Fig. 6-3B). However, for TbTIF2, the effect was the same as in the
control cells (Fig. 6-3B). No major changes in the size distribution of TERRA
molecules were detected (Fig. 6-3B). In the slot blot analysis, RNA collected
before and after depletion of telomeric proteins was blotted on the memb rane
followed by hybridization with the (*CCCTAA)133 probe. Figure 6-3C shows
increases in TERRA amount upon depletion of TbRAP1 and TbTRF, suggesting
that both proteins play important roles in TERRA expression regulation. A mild
increase in TERRA level was also seen upon depletion of TbTIF2 (Fig. 6-3C).
However, quantification of signals obtained from slot blot analyses (Figure 6-3D)
showed that TbTIF2’s effect on the steady state level of TERRA was not
significantly different from the vector control cells (P= 0.1974). In contrast,
depletion of TbRAP1 and TbTRF showed significant increase in the steady state
level of TERRA. TbRAP1 appeared to have more profound effect on TERRA
levels (~10 fold) compared to TbTRF (~5 fold). This suggests that different
telomeric proteins may contribute differently to TERRA expression regulation.
Telomeres contributing to TERRA transcription
As previously described (Rudenko and ploeg 1989), transcription of TERRA
RNA in T. brucei is not sensitive to α-amanitin treatment, indicating that unlike
mammalian systems, TERRA in T. brucei is not transcribed by RNA polymerase
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II but likely by RNA polymerase I. In T. brucei, the active VSG is transcribed
exclusively from one of ~15 BESs located at subtelomeres by RNA polymerase I
(Gunzl et al. 2003, Hertz-Fowler et al. 2008). Hence, it is possible that the
majority of TERRA RNA might be transcribed as a result of read-through from the
telomere transcribing the active VSG. T. brucei

has 11 pairs of megabase

chromosomes carrying all essential genes, ~5 intermediate chromosomes, and
~100 of minichromosomes carrying mostly repetitive sequences (Weiden et al.
1991, Zomerdijk et al. 1992, Alsford et al. 2001, Wickstead et al. 2004). There
are ~250 telomeres in a T. brucei nucleus (Figure 6-4).
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Figure 6-4: Total telomeres in a T. brucei nucleus. T. brucei consists of 11 pairs
of megabase chromosomes and ~5 intermediate chromosomes. Among these
~54 telomeres, 15-20 are known to carry the well-characterized BESs. However,
for the rest of 35-40 telomeres no sequence information is available for the
subtelomeric region. The rest of ~200 telomeres are on minichromosomes. Many
of these telomeres carry a VSG gene at the subtelomeric region.
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Although minichromosomes carry a VSG gene at their subtelomeric region, it
is known that no active transcription occurs on minichromosomes due to the lack
of an upstream promoter. Hence, out of these ~250 telomeres only ~54
telomeres have a possibility of active transcription at the subtelomeric region. 1520 telomeres on megabase and intermediate chromosomes carry a BES at their
subtelomeric regions. Sequences of these BESs are well known, allowing their
easy characterization. We can also easily differentiate telomeres marked with the
active VSG from those with silent VSGs. However, for the rest of the 35-40
telomeres on the megabase and intermediate chromosomes, no sequence
information is available for the subtelomeric region. Due to lack of sequence
information it is difficult to test whether any transcription occurs at these
telomeres. We hypothesized that TERRA is transcribed from the telomere
carrying the active VSG. In order to test this possibility, we collected total RNA
from cells exclusively transcribing VSG2 and cells exclusively transcribing VSG6.
RNA

was reverse

transcribed

using

a telomeric backward primer (5’

CCCTAACCCTAA 3’). This would lead to reverse transcription of all the TERRA
containing transcripts since TERRA contains UUAGGG repeat sequences. After
reverse transcription, PCR was performed using primers specific to the active
and silent VSGs and cDNA as the template (Figure 6-5 A &B). Although we do
not know the structure of mature TERRA transcripts, we are aware that TERRA
is transcribed from chromosome internal region towards the telomere. In addition,
T. brucei genes are transcribed in a polycistronic fashion, so is the transcription
of BESs. Hence we predict that we will be able to detect precursor and/or mature
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TERRA molecules using primers specific to VSGs located immediately upstream
of telomeres if TERRA is polycistronically transcribed with other genes in the
BES by RNA polymerase I. In addition, we predict that only primers specific to
the active VSG can amplify the RT product but not primers specific to silent
VSGs, if only the active BES transcription contributes significantly to TERRA
expression.
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Figure 6-5: TERRA transcription from an active ES. (A) cDNA and gDNA
(genomic DNA) was obtained from BF cells exclusively expressing VSG2 and
from PF cells where no VSG is expressed. PCR was performed using primers
specific for VSG2 and VSG6. (B) cDNA and gDNA (genomic DNA) was obtained
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from BF cells expressing exclusively VSG6 and from PF cells. PCR was
performed using primers specific for VSG2 and VSG6.
As seen from figure 6-5A, a PCR product was obtained using VSG2 primers
when cDNA obtained from BF cells expressing VSG2 was used as the template.
VSGV6 is silent in these cells. No product was obtained using VSG6 primers
when the same cDNA was used as the template. PF cells do not express any
VSGs. No PCR product was obtained using either VSG2 or VSG6 primers when
cDNA prepared from PF cells was used as the template. Genomic DNA from
either BF or PF cells gave amplification products when both VSG primers were
used, indicating that lack of PCR product in the reactions using cDNA as the
template was not due to loss of either VSG gene. Similarly, in figure 6-5B, a PCR
product was obtained using VSG6 primers when cDNA obtained from BF cells
expressing VSG6 was used as the template. No product was obtained using
primers specific to the silent VSG2. CDNA obtained from PF cells did not give
any amplification using either VSG6 or VSG2 primers. However, products were
obtained when genomic DNA was used as a template, indicating that both VSG
genes were present in these BF and PF cells. These results suggest that a
significant amount of TERRA RNA is transcribed from the telomere with the
active VSG in BF cells. On the other hand, in PF cells TERRA RNA appears not
transcribed from any of the BES marked telomeres. It is possible that in PF cells
TERRA might be transcribed from other telomeres whose sequence information
is not available. In the future, sequencing of TERRA RNA from PF cells can be
carried out to help a better understanding of its transcription.
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TERRA RNA in BF cells is transcribed form the telomere carrying the active
VSG
We found that transcription of the active BES contributes significantly to
TERRA expression in BF cells (Fig. 6-5). To confirm this discovery, we used an
alternative independent approach. It is known that the active VSG marked
telomere undergoes frequent truncations, possibly due to its highly transcribed
status (Bernards et al. 1983). In addition, in the absence of telomerase, the
active VSG marked telomere is not elongated after each truncation, resulting in
this telomere being shortened within a short period time (Dressen and Cross
2006). We decided to take advantage of this notion and obtained a telomerase
null clone where most telomeres still have similar sizes as those in WT cells but
the active VSG marked telomere is less than 1 kb long (Fig. 6-6). We
hypothesized that TERRA RNA size distribution will be affected when the active
telomere is much shorter than other telomeres if the majority of TERRA is
transcribed from the active telomere. We also expected to detect a TERRA
transcript of precise size (in contrast to a smear) in these cells if the mature
TERRA molecules are processed at defined positions since the active telomere
has a precise size in these clonal cells.
Ranjodh Sandhu in our lab did limiting dilution of BF TbTRDKO cells
(telomerase RNA null cells) and obtained a clone with extremely short active
VSG2-marked telomere. Specifically, cells were plated at the density of 1
cell/well. After reaching an appropriate concentration, cells were harvested, and
Southern blot analysis was performed to determine the size of the VSG2-marked
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telomere (Fig. 6-6). The clone with the shortest active telomere was used for
subsequent studies. It is important to note that this clone was obtained within a
short range of time (~15 weeks), a time during which except for the active
telomere, the majority of the bulk telomeres were still long and have similar sizes
to wild-type telomeres. The parent BF TbTRDKO cells were also cultured for ~2
weeks, a time during which all the telomeres are long and were used as a control
to exclude any possible effect of TbTR deletion on TERRA.
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Figure 6-6: Establishing TbTRDKO cells with short active ES-marked telomere.
(A) Schematic representation of TbTRDKO cell lines on the left. A freshly
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obtained clone of TbTRDKO (~2 weeks BF TbTRDKO) had telomeres of same
sizes as those in wild-type BF cells (WT BF). After limiting dilution, a clonal
population was obtained that has a very short active VSG-marked telomere
(within 15 weeks), with the rest of the bulk telomeres still long. (B) Southern blot
analysis to determine bulk telomere length in all cell lines. Left panel shows the
Ethidium Brimide (EtBr) staining of the agarose gel before hyb ridization. Right
panel shows hybridization results with telomere specific probe. (C) Southern blot
analysis to determine the size of the active VSG2-marked telomere all cell lines.
VSG2 BES has an EcoRI site upstream of the VSG2 gene. Upon digestion with
EcoRI, a terminal restriction fragment is obtained from which the telomere length
can be calculated. The Southern blot was hybridized with a VSG2 specific probe.
As seen from figure 6-6B, wild-type cells and TbTRDKO (~2 weeks) cells
have telomeres of comparable sizes. The short time cultured (~15 weeks) clone
obtained after limiting dilution has only a mild telomere shortening phenotype
with the sizes of bulk telomeres ranging from ~2 to 12 kb and still similar to those
in wild-type cells. Southern blot analysis using the VSG2 probe showed that wildtype and TbTRDKO cells cultured for 2 weeks have terminal VSG2 restriction
fragments of ~12 kb (figure 6-6C). This indicates that in both of these cell lines
the telomere adjacent to VSG2 is long and more than 10 kb. While TbTRDKO
cells cultured for 15 weeks have a terminal VSG2 restriction fragment of less
than 3 kb, indicating that the size of VSG2 marked telomere is only 600-800 bp
long. Thus we successfully obtained a n experimental system to determine the
effect of a shortened active telomere on TERRA transcription without altering the
lengths of bulk telomeres. This will further aid in confirming that transcription of
the active BES-marked telomere contributes significantly to the total amount of
TERRA.

159

Figure 6-7: Amount of TERRA transcript in TbTRDKO cells and VSG
derepression analysis. (A) Northern blot analysis to determine the size
distribution of TERRA RNA in wild-type cells and TbTRDKO cells cultured for 2
weeks (carrying >10 kb long VSG2-marked telomere) or for 15 weeks (carrying
<1 kb VSG2-marked telomere). The rRNA precursor is shown as a loading
control. (B) Slot blot analysis to determine the amount of TERRA in wild type
cells and TbTRDKO cells. Tubulin is probed as an internal loading control. The
quantification result is shown below the slot blot. TERRA expression level is
calculated as percent of that in wild-type cells (BF WT). All samples are
normalized against the tubulin hybridization signal. (C) Quantitative RT-PCR was
performed to measure steady state mRNA levels of various VSGs in TbTRDKO
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cells cultured for 2 or 15 weeks. VSG mRNA levels in wild type cells are used as
the normalization standard and are set to 1 (not shown in the figure). Fold
difference in mRNA levels compared to wild type cells are calculated from three
independent experiments. Tubulin mRNA amount was used as an internal
loading control.
We collected RNA from all these cell lines and performed northern blot
analysis to determine the size distribution of TERRA molecules. RNA samples
were separated by agarose gel electrophoresis followed by in gel hybridization
with radioactively labeled (*CCCTAA)133 probe (figure 6-7A). TERRA sizes range
from 1.0 to 10 kb in both wild type BF cells and TbTRDKO cells cultured for only
2 weeks, indicating that TERRA is not affected by the telomerase null
background per se. However, in TbTRDKO cells cultured for 15 weeks that carry
the short (<1 kb) active VSG2-marked telomere, TERRA size distribution was 2-8
kb. The larger sized (~ 10 kb long) molecules were not observed in these cells,
suggesting that shortening of the active VSG2-marked telomere affected TERRA
size distribution. We did not observe a sharp band of TERRA molecules,
suggesting that the mature TERRA may not be processed at precise locations.
Importantly, even though equal amount of RNA was loaded for all three lanes
(figure 6-7A), the signal for TERRA was the weakest for the TbTRDKO cells
cultured for 15 weeks, indicating that the total amount of TERRA transcripts is
decreased. We subsequently performed slot blot analysis to better quantify the
amount of TERRA transcripts. As seen in figure 6-7B, we observed a more than
70% decrease in the amount of TERRA transcripts when the active telomere is <
1 kb long. This result supports our hypothesis that a significant amount of
TERRA is transcribed from the active telomere. However, our probe only
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recognizes the telomeric sequence, hence the decrease in northern blot
hybridization signal might be just due to the lack of telomeric repetitive
sequences in TERRA transcripts rather than indicating a lower level of TERRA
expression. Northern analysis using a subtelomeric probe should be able to
distinguish between these two scenarios in the future. In either case, our
hypothesis that a significant amount of TERRA is contributed by transcription of
the active telomere holds true.
We hypothesize that TERRA might be involved in VSG silencing regulation. In
order to test this possibility we have been trying to achieve knock down of
TERRA using RNAi. Despite of using various versions of RNAi constructs we
have not yet achieved knockdown of TERRA. Since we observed a decreased
TERRA amount in TbTRDKO cells cultured for 15 weeks, we decided to test
whether VSG silencing was affected in these cells. Total RNA was collected from
wild type and TbTRDKO cells cultured for 2 or 15 weeks and subjected to
reverse transcription. Quantitative RT-PCR was subsequently performed using
VSG specific primers to detect steady state mRNA levels of several VSGs.
Indeed, we observed 3-5 folds of de-repression of silent VSGs in TbTRDKO cells
cultured for 15 weeks. This result suggests that TERRA is important for VSG
silencing.
DISCUSSION
Telomere transcription has been recently detected in a number of organisms.
However, many facts about TERRA still remain to be discovered. Most
importantly, the biological functions of TERRA are not well known. Telomere
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transcription in T. brucei was discovered long ago. However, no further studies
were carried out. Our lab is focused on understanding the regulation of VSG
silencing in T. brucei. In mammalian system TERRA is known to be important for
forming heterochromatic region around telomeres, and depletion of TERRA leads
to telomere dysfunction (Deng et al. 2009). In T. brucei VSGs are expressed from
subtelomerically located BESs and it is well established that telomeres play an
important role in their regulation (Yang et al. 2009, Benmerzouga et al. 2013,
Pandya et al. 2013). Hence, we are interested in determining whether TERRA
plays any role in VSG silencing regulation.
TERRA RNA size ranges from 0.5 to 10 kb in wild-type BF cells and from 0.5
to 1.5 kb in PF cells. This striking difference between different stages of T. brucei
life cycle is very interesting and suggests a possible different nature of TERRA
transcripts in both forms. In addition, TERRA is mostly transcribed from the Crich strand in BF cells, but in PF cells both strands appear to be transcribed. At
this point it is unclear whether TERRA exists as dsRNA in PF cells. All VSGs are
silent in PF and a different surface coat composed mainly of procyc ylins is
expressed. This different nature of TERRA transcripts can be due to different
roles played by TERRA at life cycle stages. Since the BF form of T. brucei is
clinically more important, we decided to focus on this stage for further studies.
Telomeric proteins, such as TRF1 and TRF2 interact with TERRA in
mammalian cells (Deng et al. 2009). Our preliminary RNA IP results in T. brucei
showed that TbTRF and TbKU80 interact with TERRA, while TbRAP1 and
TbTIF2 do not. Additional controls are needed, such as RNase A treatment
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before IP to prove that the signals obtained is solely due to direct interaction
between protein and RNA. Although all IP products were treated with DNase I, it
will be important to perform DNase I treatment before IP to exclude any DNAmediated interactions.
We found that depletion of TbRAP1 and TbTRF elevated TERRA levels.
Depletion of TbTIF2, on other hand, did not significantly affect TERRA levels.
However, it seems that TERRA levels are high even before TbTIF2 RNAi
induction (figure 6-3 B lane 5), suggesting that there might be leaky expression of
TbTIF2 RNAi in this cell line. Different clones will be used in future analysis to
determine whether TbTIF2 plays any role in regulation of TERRA. Effects of
TbRAP1 and TbTRF depletion on TERRA levels were different (~10 and ~5 fold
increase, respectively) even though both proteins were knocked-down at similar
levels. From IP results we know that TbTRF interacts with TERRA while TbRAP1
does not. TbRAP1 depletion in BF cells leads to de-repression of silent
subtelomeric VSGs, while TbTRF does not affect BES-linked VSG silencing.
Therefore, TbRAP1 and TbTRF probably regulate TERRA levels through
different pathways. Our previous studies suggest that TbRAP1 may affect
transcription elongation along silent BESs and therefore affect VSG silencing. It
is possible that TbRAP1 regulates TERRA expression in a similar way. TbTRF,
on the other hand, may play a post-transcriptional role in maintaining stability of
TERRA transcripts.
TERRA transcription in T. brucei is not sensitive to α-aminitin treatment
(Rudenko & Ploeg 1989), suggesting that it is not transcribed by RNA
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polymerase II or III. BESs are located at subtelomeres in T. brucei and are
transcribed at very high level by RNA polymerase I. We hypothesize that TERRA
might result from transcription read through of the active BES-marked telomere.
Indeed, RT-PCR analysis suggests that a significant amount of TERRA is
transcribed from the active BES-marked telomeres. It is possible that TERRA
might be transcribed from other telomeres as well. Metacyclic VSGs in T. brucei
are transcribed from monocistronic transcription units (MES) located at
subtelomeres. We will perform RT-PCR analysis to test whether TERRA can be
transcribed from these MES-marked telomeres. However, our current knowledge
does not allow us to test transcription from telomeres unmarked by any VSG
transcription unit.
We have taken an independent approach to prove that TERRA is mostly
contributed by transcription of the active telomere. We obtained a TbTR deletion
cell line carrying only the shortened active telomere and long bulk telomeres.
Northern analysis showed that TERRA size distribution was affected and longer
transcripts were absent in the cells carrying a shortened active telomere. We did
not observe a sharp band of TERRA RNA product even through the active
telomere has precise size in the clonal population, suggesting that trans-splicing
of TERRA may not occur at a precise location. Importantly, in the cells carrying a
shortened active BES-marked telomere, the TERRA levels were significantly
reduced and several silent VSGs were mildly de-repressed. It is possible that
such derepression of silent BESs might lead to transcription of TERRA from
these previously silent telomeres. Strikingly, the VSG de-repression phenotype
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was very interesting, as it suggests that TERRA can influence VSG silencing and
that its levels are regulated in wild type cells. Depletion of TERRA in the future
would help to confirm this function of TERRA in T. brucei.
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CHPATER VII
SUMMARY AND FUTURE PERSPECTIVES

Roles of TbRAP1 in VSG silencing
Telomeres play an important role in VSG silencing. TbRAP1, a telomeric
protein was previously identified to regulate ES-linked VSG silencing in BF cells
(Yang et al. 2009). We further established that TbRAP1 also regulates ES-linked
VSG silencing in PF cells (where essentially all VSGs are silent). TbRAP1 is an
essential protein and its depletion affects cell growth in the PF stage. Metacyclic
VSGs are kept silent at BF and PF stages. So far, not much is known about its
regulation. We determined that TbRAP1 is required for mVSG silencing at both
BF and PF stage. The strength of the TbRAP1 mediated VSG silencing is
stronger in PF cells compared to that in the BF cells. This is likely due to the fact
that BF cells need to switch their active VSG regularly and, hence, VSGs might
be less tightly regulated. On the contrary, in PF cells expression of VSGs is
detrimental for the parasite survival and hence a stronger regulation is required.
Interestingly, TbRAP1 regulates VSG silencing at the PF stage through
chromatin remodeling.

.
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Depletion of TbRAP1 in PF cells led to more opened chromatin structure at
ES-linked VSGs, mVSGs, and minichromosome VSGs. However, no significant
change in chromatin structure was detected in BF cells. This interesting
contradiction in mechanisms gives rise to several interesting models (discussed
in Chapter III). One possible reason is the presence of additional regulatory
mechanisms in BF cells. In the future, simultaneous depletion of TbRAP1 and
histone H1 or base J can be preformed to determine whether there is any
additional effects on VSG transcription and chromatin structure.
TbRAP1 was found to associate preferentially with silent ES-marked
telomeres compared to the active ES-linked telomere in BF cells. Although the
data are preliminary, they provide some interesting insights into the mechanism
of TbRAP1 mediated VSG silencing. TbRAP1 needs to be physically bound to
the chromatin to carry out its nearby gene silencing. Several studies suggest that
epigenetic regulation is involved in VSG silencing. Previously, it was established
that depletion of TbSir2rp1 (yeast Sir2 homolog) affected subtelomeric silencing
without affecting VSG transcription (Alsford et al. 2007). In contrast, depletion of
histone deacetylase DAC3 affected ES promoter transcription (Wang et al.
2010). Finally, depletion of histone methyltransferase Dot1B affected VSG
expression mildly (Figueiredo et al. 2008). Interestingly, unlike the mammalian
and yeast homologues, T. brucei Dot1b lacks a chromatin-binding domain,
suggesting an additional player is required for its recruitment to the chromatin
(Frederiks et al. 2010). It is interesting to propose that TbRAP1 may recruit these
factors to regulate VSG silencing. In the future, Co-Immunoprecipitation can be
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performed to determine whether TbRAP1 interacts with these factors. Upon
TbRAP1 knockdown, the derepressed VSGs are expressed at a level that is still
100 – 1,000 fold lower than that of the active VSG. Simultaneous depletion of
TbRAP1 and these factors can be carried out to determine whether there is any
additional effect on VSG expression.
It will be crucial to determine how TbRAP1 is recruited to the telomere,
knowing that TbRAP1 regulates VSG silencing and that it is preferentially bound
to the silent ES-linked telomeres. It is thought so far that TbTRF recruits TbRAP1
to the telomere. No direct telomere DNA binding activity of TbRAP1 was
observed by EMSA. However, further experiments are required to confirm this
finding. Interestingly, unlike TbRAP1, TbTRF did not show preferential binding to
the ES-linked telomeres, suggesting that TbRAP1 might be recruited to
telomeres through an additional factor. Another piece of evidence comes from a
very preliminary work, where depletion of TbTRF did not affect the binding of
TbRAP1 to the telomere (data not shown). Instead, in a few cases, increased
binding for TbRAP1 to the telomeres was observed upon TbTRF depletion. This
not only suggests that TbRAP1 has a TbTRF-independent mode of recruitment
but also suggests that TbTRF and TbRAP1 likely compete with each other for
telomere binding. Previous work in our lab by Dr. Yang found that TbRAP1 can
co-immunoprecipitate with histones. It is possible that TbTRF might still be a
primary means for TbRAP1 recruitment to the telomere. However, TbRAP1 might
also interact with histones or additional factors to be targeted to silent ES-linked
telomeres. The TbTRFH domain in TbTRF is known to interact with TbRAP1. We
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have established several TbTRFH mutants (discussed in Chapter V). Analyzing
loss of interaction mutants in vivo can further shed light on recruitment of
TbRAP1 to the telomere.
TbRAP1 was found to be important for maintaining telomere G-overhang
length. Depletion of TbRAP1 led to a decrease in G-overhangs signal when
analyzed by in-gel native hybridization. It is known that in mammalian cells, DNA
damage at telomeres results in reduced histone biosynthesis (Sullivan et al.
2010). Additionally, in budding yeast it was fo und that during senescence (due to
telomere shortening), ScRAP1 binds to the promoters of core-histone encoding
genes and repress their transcription (Platt et al. 2013). We wanted to test
whether histone levels were affected upon TbRAP1 depletion.
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Figure 7-1: Histone levels upon TbRAP1 depletion. (A) RT-PCR analysis was
performed to measure steady state mRNA levels of histone H3 before (day 0)
and after (day 2 and 3) depletion of TbRAP1 in PRi-pool cells (PF). Fold change
in mRNA level was calculated compared to day 0 whose value was arbitrarily set
to 1.Total cell lysate was collected before and after depletion of TbRAP1 in (B)
PRi-pool (PF), (C) Ri-CT and Ri-BRCT (BF) cells. Levels of histone H2A and
histone H3 was determined by western analysis using antibodies specific to
histone H2A and H3.
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We determined whether TbRAP1 depletion affected levels of histones in PF
and BF cells. No change in mRNA levels of histone H3 was observed upon
depletion of TbRAP1 in PF cells (figure 7-1 A). However, the protein levels of
core histones H2A and H3 were decreased upon depletion of TbRAP1 in both PF
and BF cells (figure 7-1 B and C). The decrease in the levels of histone protein
was similar to that of the TbRAP1 protein in PF cells (figure 7 -1 B, day 2)
possibly explaining the loosening of chromatin structure observed upon TbRAP1
depletion. However, in BF cells the depletion of histones was observed at much
later stage after TbRAP1 depletion (figure 7-1 C, 24 and 36 hours). We know that
even at later stages the chromatin structure in BF cells remains unaffected even
though the total histone protein level decreased. However, we only analyzed ES
loci during FAIRE experiments and it is possible that its chromatin compaction
may still remain unaffected. Another possible reason might be due to the
presence of linker histone H1, which is known to form a higher order chromatin
structure. Depletion of histone H1 affects chromatin structure only in BF cells,
suggesting its role in maintaining higher order chromatin compaction at this stage
(Povelones et al. 2012). Western blot analysis could not differentiate between the
nucleosome bound versus the nucleosome free fraction of histone proteins.
Hence it is not clear at this moment that the decline observed is in free fraction or
nucleosome bound fraction or both. Also, T. brucei histones are very divergent
hence; due to lack of specific antibodies it is not feasible at this time to test levels
of all histone proteins or specifically modified histones. TbRAP1 depletion leads
to cell growth arrest in PF and BF cells. Is there a DNA damage response? Is the
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depletion of levels in histone due to trigger of such pathways and is it related to
growth arrest? If so can histones (being highly divergent) be used as a drug
target? These are few interesting questions that to be answered need further
research in the future.
TbTRF and its role at telomeres
TbTRF directly binds to telomeric DNA (Li et al 2005). The homodimerization
domain of TbTRF is required for self-dimerization of TbTRF as well as for
interaction with other telomeric proteins, such as TbRAP1 and TbTIF2. We
speculate that TbTRF acts at the center of the telomeric complex and holds the
entire complex together. Depletion of TbTRF leads to very acute growth arrest (Li
et al. 2005), making it impossible to elucidate all of its function in telomere end
protection. We established seven TbTRFH domain mutants and tested their
interaction with wild-type TbTRF and mutant TbTRF in vitro. We determined the
helices required for TbTRF homodimerization function. In the future, these
mutants can be utilized to determine critical helices required for interactio n with
other telomeric proteins. Loss of interaction mutants can then be introduced in
vivo to study the role of TbTRF in telomere complex maintenance and telomere
protection.
Depletion of TbTRF does not lead to ES-linked VSG derepression in BF and
PF cells (Li et al. 2005). For VSG derepression to occur, a certain level of
functional transcription machinery is required in the cell. TbTRF depletion had a
very acute growth arrest and it is possible that due to disruption of the whole
telomeric complex and trigger of DNA damage response we do not observe VSG
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derepression. However, TbTRF being directly bound to telomeric DNA we
wanted to determine whether it has any role in chromatin remodeling at
telomeres. Depletion of TbTRF led to more opened chromatin structure at ESlinked VSGs in PF but not BF cells. TbTRF depletion did not affect transcription
of mVSGs, however, loosening of chromatin structure was observed at mVSGs
in PF cells. These results collectively suggest that TbTRF possesses the ability
to modulate chromatin at telomeres. In the future, mutants of TbTRF can be
utilized to study its role in regulating VSG silencing.
TERRA and its function in antigenic variation
Telomeres are transcribed into long non-coding RNA called TERRA. TERRA
was reported in T. brucei in 1989 but no further characterization was performed
(Rudenko and Ploeg 1989). With increasing knowledge of TERRA function in
telomere regulation, we decided to characterize it and to determine whether it
plays any role in antigenic variation. We characterized that TERRA is transcribed
from the C-rich strand in BF cells and from both strands in PF cells. RNA-IP
determined that TERRA interacts with TbTRF and TbKU80, but not with TbRAP1
and TbTIF2, suggesting that TERRA might be associated to telomeres through
the telomeric complex. However, its association with telomeres in vivo needs to
be determined.
Telomeric protein TbRAP1 and TbTRF regulates TERRA transcription and
their depletion leads to elevated levels of TERRA, suggesting that telomeric
complex regulates TERRA expression. Elevated or deregulated TERRA
transcription is known to induce telomere shortening in yeast (Sandell et al. 1994,
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Maicher et al. 2012). Hence, it is very important to regulate its level in vivo and it
seems that in T. brucei telomeric complex is one of the key regulators of TERRA
transcription. By performing PCR analysis we determined that within ES -linked
telomeres, TERRA is transcribed from active ES. This result correlates with the
high RNA Pol I mediated transcription of active ES. Most interestingly, shortening
of the active ES-linked telomeres led to a significant decrease in the amount of
TERRA molecules and mild derepression of silent ES-linked VSGs. Thus, we
hypothesize that TERRA plays a role in antigenic variation and it regulates VSG
silencing at least in BF cells. However, to confirm its role in VSG silencing and to
study its function in PF cells, it is critical to achieve knockdown of TERRA. So far,
all the efforts to knockdown TERRA by RNAi have been fruitless and all the
strategies employed were unsuccessful. In the future alternative strategies need
to be employed to achieve knock down of TERRA molecules.
The work performed in this thesis collectively determined that telomeres are a
key regulator of antigenic variation in T. brucei. We have further contributed to
the understanding of pathogenesis of T. brucei. This knowledge can be applied
towards the eradication of this parasite in the future.
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